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Abstract
Neurosteroids are compounds synthesized de novo within the central nervous
system and affect brain function via genomic and non-genomic mechanisms. Sulfated
neurosteroids modulate synaptic neurotransmission via interactions with various
membrane receptors located at pre- and/ or postsynaptic sites, including metabotropic and
ionotropic neurotransmitter receptors and ion permeable channels. The interactions of
sulfated neurosteroids with these types of targets can induce rapid changes in
neurotransmitter release and/or in postsynaptic responses. Since the 1940's, pregnenolone
sulfate (PregS), the sulfated version of the steroid precursor, pregnenolone, has been
suggested to have anti-stress, anti-aging, antidepressive, neuroprotective and memory
enhancing effects in the mature brain. However, little is known on the physiological role
of PregS in the development of the brain. Previous studies from our laboratory have
postulated PregS as a novel enhancer of excitatory neurotransmission in the
hippocampus, a brain area important for learning and memory. In the work presented
here, we evaluated the effects of PregS in the developing rat cerebellum. The cerebellum
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is a brain region essential for motor coordiation, balance and equilibrium, muscle tone,
and cognitive and language functions. We found that PregS potently and reversibly
enhanced the release of the excitatory neurotransmitter, glutamate, onto neonatal Purkinje
cells (PCs), which provide the sole output from the cerebellar cortex. This effect of PregS
was present at the climbing-fiber-to-PC synapse, a powerful glutamatergic synapse
important for the timing of conditioned reflexes. Interestingly, the mechanism responsible
for this effect of PregS is mediated by a Ca2+ permeable cation channel, the transient
receptor potential melastatin 3 (TRPM3) channel. This channel was recently shown to be
sensitive to PregS and to be involved in a number of physiological events in the
periphery. However, its role in brain physiology is unknown. Thus, the studies presented
here postulate TRPM3 channels as novel modulators of excitatory neurotransmission in
the immature brain. In addition, we found that TRPM3 channels are highly expressed in
all layers of the developing cerebellar cortex. This finding suggests that these steroidsensitive channels play a major role in the development of this brain region. Lastly, we
found that pharmacologically-induced increases in endogenous PregS-like neurosteroids
potentiate glutamatergic transmission at PCs in organotypic hindbrain cultures. This
finding sets up the stage for future experiments that will investigate the effect of TRPM3
channels and endogenous PregS in the development of the cerebellar cortex.
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1. INTRODUCTION
1.1 Overview of the cerebellum
The cerebellum is an area of the hindbrain known for its important role in motor
movement coordination, balance and equilibrium, and muscle tone. Interestingly, the
cerebellum has undergone a significant size enlargement through evolution, which
occurred in parallel with the acquisition of higher human cognitive skills, such as
language (Leiner, 2010). Over the last three decades, it has been demonstrated that the
cerebellum does not only communicate with motor and sensory regions in the cerebral
cortex, but it is also heavily interconnected with areas involved in cognitive and language
functions, and even with brain regions associated with affective states (Schmahmann and
Sherman, 1997, Strick et al., 2009). These cerebro-cerebellar connections are arranged in
a closed-loop fashion where a specific cerebellar output channel within the cerebellar
nuclei provides the main synaptic input to a specific cerebellar cortical area and vice
versa (Strick et al., 2009). Parallel to anatomical evidence for the role of the cerebellum
in higher and executive brain functions, a plethora of functional evidence has been
presented (Strick et al., 2009, Leiner, 2010, Stoodley and Schmahmann, 2010). These
studies have shown that patients with cerebellar damage present not only motor
syndromes such as dysmetria, dysarthria, and ataxia but also executive, visual spatial, and
linguistic impairments, as well as affective dysregulation (reviewed in (Stoodley and
Schmahmann, 2010)). It is then apparent that dysregulation of cerebellar circuitry
functions can have widespread adverse effects in overall brain function. Clear examples
for these are the cerebellar dysfunctions caused by acute and chronic ethanol intoxication,
which include dysarthria, nystagmus, ataxia, intention tremor, and executive function

alterations. The latter are likely caused by damage of the connections between the
cerebellar hemispheres and the frontal cortex (reviewed in (Valenzuela et al., 2010)).
Furthermore, alterations in cerebellar cortex development and synapse formation have
been found to be implicated in the pathophysiology of autism, schizophrenia and ataxia ,
which are accompanied by cognitive impairments and emotional symptoms (Ito-Ishida et
al., 2008, Stoodley and Schmahmann, 2010).

PC
GC

Molecular

GoC
BC/SC

Purkinje

CF
MF

PF

Granule

Figure 1.1. Schematic representation of the cerebellar cortical layers and their cellular
components. PC: Purkinje cell; GoC: Golgi cell, GC: granule cell, BC: basket cell (located more
basally), SC: stellate cell (located more apically), MF: mossy fiber, CF: climbing fiber, PF:
parallel fiber. The molecular, Purkinje, and granule cell layers are indicated at the bottom (From
Valenzuela et al 2010).
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The cerebellum contains the largest number of neurons of any region of the brain
and its structure is comparable to that of computing machines. Basic components are
assembled into modular packages that contain similar circuitry and large numbers of such
similar modules are organized into parallel processing networks, each of which sends a
bundle of fibers to specific parts of the cerebral cortex (Leiner, 2010). The cerebellar
cortex contains the circuitry modules that compute the information from the cerebral
cortex. This cortex receives external inputs form the inferior olive, thought to encode the
timing of sensory input (reviewed in (Liu et al., 2008a)), and from various areas of the
cerebral cortex, the vestibular system, the spinal cord, and the reticular formation via the
mossy fibers (reviewed in (Dean et al., 2010)).
The only output from this cerebellar region are the Purkinje cells (PCs), which
send the processed information to the deep cerebellar nuclei for final integration (Jaeger,
2011). PCs are GABAergic neurons arranged as a monolayer located in between the
granule cell layer and the most superficial layer, the molecular layer (Figure 1.1). PCs
receive inhibitory input from GABAergic interneurons in the molecular layer, namely the
stellate (SCs) and basket cells (BCs). The cell bodies of the SCs populate the most
external two thirds of the molecular layer, whereas the cell bodies of BCs are located in
the one third closest to the PCs bodies. BCs synapse onto the initial segment of the PC
axon, forming the pinceaux synapse, where interbasket fiber septate-like junctions also
establish unique axoaxonic synapses (Sotelo, 2008). On the other hand, SCs synapse on
the planar and extensive dendritic tree of the PCs, which traverses the molecular layer.
PCs receive excitatory, glutamatergic input from the parallel and the climbing fibers, PFs
and CFs, respectively (Figure 1.1). The former arise from the bifurcated axonal
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projections of granule cells in the granule cell layer, and the latter correspond to the
axons of inferior olivary neurons. PFs synapse onto the distal dendrites while the CF
synapses onto the proximal dendrites. These two types of axonal projections also
communicate to SCs and BCs, but while PFs directly synapse onto these interneurons,
CFs communicate via glutamate spillover (Szapiro and Barbour, 2007, Cesa and Strata,
2009). Additionally, while several PFs form more than 200,000 synapses onto PCs, only
one CF arbor, containing about 300 varicosites, contacts a single PC (Cesa and Strata,
2009). PFs and CFs inputs to PCs also differ in their strength, synaptic plasticity, and
baseline release probability. PFs produce brief excitatory postsynaptic potentials
generating single action potentials, or simple spikes. Activation of PFs exhibits a stimulus
strength-dependent response, which exhibits prominent paired-pulse facilitation (PPF) of
presynaptic origin (Etzion et al., 2009). The CF induces a large (all-or- none)
depolarization of the soma and dendrites of PCs with a burst of action potentials, or
complex spike (Schmolesky et al., 2002, Cesa and Strata, 2009). Also, the CF-to-PC
synapse has been shown to operate at a baseline of high release probability and,
consistent with this, it exhibits paired pulse depression (PPD) of presynaptic origin
(Hashimoto and Kano, 1998).

1.2 Development of the cerebellar cortex.
Cerebellar neuronal precursors, in rodents, start to migrate and differentiate from
the ventricular epithelium and the rhombic lip at around embryonic day (E) 9 (Bosman
and Konnerth, 2009). Despite the early start of cerebellar development, the most active
period of cerebellar maturation occurs from birth to approximately the end of the second
postnatal week and parallels motor development (Swinny et al., 2005). In humans, this
4

period is roughly equivalent to the last trimester of pregnancy (Dobbing and Sands,
1973). Studies have shown that from 24 weeks to 40 weeks of gestation, the volume of
the human cerebellum undergoes a 5-fold increase (Volpe, 2009).

EGL

NML
PCL

IGL

P4

P7
PC

P12
CF

GoC

P21
GC

BC/SC

MF

Figure 1.2. Schematic representation of the cerebellar cortex development. At P4, GC are
migrating from the external granule layer (EGL) to the internal granule layer (IGL), where GoC
and MF are already present, - GCs migrate tangentially within the EGL and along the Bergmann
glia in the nascent molecular layer -, undifferentiated BC and SC are migrating toward the
nascent molecular layer (NML), and PCs are innervated by around 5 CFs. By P7, immature GCs
as well as BC/SCs continue to migrate; while their more mature counterparts start to innervate
PCs. Additionally, GCs start to receive GoC and MF inputs. At this stage the CF elimination
process has started. At P12, already differentiated BCs innervate the proximal dendrites of PCs
whereas SCs innervate the distal ones, while immature GC migration and CF elimination are still
in place. By the end of the third postnatal week, P21, the external granule layer disappears
completely and CF monoinnervation is achieved. Also note that by this age the axon collaterals of
PCs have disappeared. Adapted from Valenzuela et al, 2010.

At birth, the rodent cerebellar cortex contains four layers, namely, the external
granule layer, the nascent molecular layer, the PC layer, and the internal granule layer
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(Figure 1.2). The external granule layer contains proliferating granule cells, which
migrate to their final destination in the internal granule layer in a saltatory fashion,
alternating phases of forward movement with pauses, along the radial/Bergmann glia
(Chedotal, 2010). The nascent molecular layer houses newly formed stellate, and basket
cells, and immature PCs dendrites. In the PC layer, the somas of PCs, (organized in a
multilayered fashion and innervated by multiple climbing fibers) and immature
Bergmann glia are found (Douyard et al., 2007). The internal granule layer contains
sparse granule cells, the GABAergic Golgi cells, and the mossy fibers. Mossy fibers
arrive at the inner granule cell layer around postnatal day 3; the Golgi cell is present at
the time of birth and starts forming synapses onto granule cells after postnatal day 7
(Takayama and Inoue, 2006). It has been shown that granule cell migration is completed
by postnatal day (P) 21, when the external granule layer disappears (Sotelo, 2008).
Comparably, in humans, granule cell proliferation and migration starts during the third
gestational trimester and continues into the first year of life (Dobbing and Sands, 1973,
Swinny et al., 2005).

1.2.1 PC development and synapse formation.
PCs are born at E13 and after their final mitosis they migrate along radial glial
fibers over the already formed deep cerebellar nuclei into the cerebellar anlage.
Importantly PCs, undergo marked morphological and functional changes during the first
2 postnatal weeks. They merge from two to three irregular rows into a single layer,
develop an extensive, flattened, dendritic tree, and form synaptic connections (Kurihara
et al., 1997, Eilers et al., 2001, Sotelo and Dusart, 2009). At around P2, PCs grow
provisional somatic synaptic protrusions, onto which the first synaptic glutamatergic
6

connections will form (Kurihara et al., 1997, Eilers et al., 2001, Kawa, 2003). By E17,
CFs start to contact PCs. At first, PCs are innervated by multiple CFs; by the end of the
third postnatal week, all but the strongest of these fibers are eliminated through a process
of synapse competition and elimination (Bosman and Konnerth, 2009, Hashimoto et al.,
2009)
The process of CF synapse elimination is divided into three different phases. It
starts with the functional differentiation of CF inputs and it is followed by the activitydependent early and late phases of synapse elimination. The number of CFs innervating a
PC can be determined using electrophysiology techniques. In these types of experiments,
immature PCs are patch clamped and CF inputs are stimulated at different intensities. CFevoked excitatory postsynaptic current responses (CF-eEPSCs) in PCs are then analyzed
(Figure 1.3A and B). Given the characteristic all-or-none response of CF-to-PC synapses,
the amplitude of the evoked responses will remain constant until an additional CF starts
contributing to this response. Every time a CF input is recruited into the CF-eEPSC
response, its amplitude will increase in a step-like manner (Figure 1.3B). The number of
steps is indicative of the number of CF inputs and the amplitude of each CF-eEPSC step
reflects the strength of an individual CF input (Bosman and Konnerth, 2009). Using this
experimental approach, it has been shown that, previous to the start of synapse
elimination, the relative synaptic strengths of multiple CFs innervating the same PC
differ in an age-dependent manner (Figure 1.3C). The amplitudes of CF-eEPSC steps are
comparable at P3, while those at P12 are very different between the largest CF and the
smallest CF (Hashimoto and Kano, 2005). At the end of the first postnatal week, multiple
CF inputs have been functionally differentiated into one strong and a few weak ones
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(Figure 1.3D). Morphological studies have shown that at P4-7, many CFs crawl around
the PC layer; these CFs are denominated the "creeper type" and their swellings do not
aggregate at a particular PC soma, but instead scatter randomly and contact multiple PCs
at the soma and the dendrites. Also at this age, other CFs surround specific PC somata
and form aggregated terminals on them, these synapses are called the 'nest type'
(Sugihara, 2005, Hashimoto and Kano, 2008, Kano and Hashimoto, 2009). It is possible
that weak CF terminals inputs correspond to creeper type CFs and strong ones arise from
nest type CFs.

A

C

B

D

Figure 1.3. Neonatal PCs are innervated by multiple CFs. (A) Schematic representation of the
electrophysiological paradigm used to record CF-evoked EPSCs. (B) Example of the CF-eEPSC
steps in a P10 mouse PC showing sequential recruitment of two climbing fibers by increasing
stimulation strength. Scale bars 4 nA, 20 ms. (C) The number of PCs innervated by more than one
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CF reaches almost 100% around P7 and then rapidly declines. (D) The strongest CF synapse
increases rapidly in synaptic strength, while the weaker synapses remain fairly stable. (Adapted
from Bosman and Konnerth 2009 and Valenzuela et al 2010).

The mechanisms responsible for this functional differentiation are not well
understood. Nonetheless, it has been observed that in P5-9 PCs, upon PC depolarization
and/or high frequency stimulation of CFs, strong CF inputs undergo long-term
potentiation (LTP) whereas weak ones undergo long-term depression (LTD) (Bosman et
al., 2008, Ohtsuki and Hirano, 2008). This suggests that plasticity mechanisms may play
a role in the functional differentiation of multinumerary CF inputs. An early phase of
surplus CF input elimination occurs between P7 and P11. This early phase is independent
of PF inputs. The late phase of CF synapse elimination takes place between P12 and P16
and has been shown to be dependent on PF synapse formation, which starts at the end of
the first postnatal week. In GluRδ2 knockout mice, where PF-to-PC synapse formation is
impaired, the regression of CFs is normal from P5 to P11, whereas the average number of
CFs innervating individual PCs is significantly larger than that of control mice from P12
afterward (Hashimoto and Kano, 2008).
The formation of GABAergic synapses onto PCs also occurs early in postnatal
life and ends by P21. The first GABAergic interneurons to contact PCs are the BCs
(Takayama and Inoue, 2004a). The formation of BC-to-PC synapses (the pinceaux
synapse) starts at around P7 (Ango et al., 2004, Sotelo, 2008). However, functional
GABAergic synapses have been detected as early as P2 (Kawa, 2002). These early
GABAergic synapses could be axonal collaterals from neighboring PCs, which mediate
GABAA receptor–dependent traveling waves of activity in neonatal P4-P14 PCs, but not
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in mature PCs. These GABAergic traveling waves may play a role in the maturation of
cerebellar circuitry (Watt et al., 2009).
During the period prior to the formation of GABAergic synapses onto PCs,
GABAA receptors can depolarize the membrane potential and activate voltage-gated Ca2+
channels. These excitatory actions of GABAA receptors have been suggested to
contribute to the activity-dependent maturation of cerebellar cortical circuitry
components, including climbing fibers (Eilers et al., 2001, Watt et al., 2009).

1.2.2 Modulators of brain maturation
During the rat neonatal period, the proper development of the PC dendrites and its
synaptic connections, are facilitated by a number of endogenous factors acting as
anterograde and/or retrograde messengers. These modulating factors include: brain
derived neurotrophic factor, polysialic acid, neural cell adhesion molecule, glutamate and
GABA, and neurosteroids (Levenes et al., 2001, Tsutsui et al., 2003, Duguid and Smart,
2004, Duguid et al., 2007, Huang et al., 2007b). In the development of brain cortical
structures, some factors influence synapse formation by acting as modulators of synaptic
transmission. It is known that glutamate signaling regulates nearly all aspects of synapse
formation and maturation. Likewise, GABA transmission has been shown to have trophic
effects on neurite growth during the embryonic and perinatal periods, which is largely
explained by the GABA depolarizing action in immature neurons that triggers Ca2+ influx
and intracellular signaling cascades (Huang et al., 2007b). Therefore, factors that
modulate neurotransmitter release as well as the activation of neurotransmitter receptors
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and Ca2+ channels are potential players in the process of synapse formation and
maturation.
During development, spontaneous as well as experience-generated synaptic
transmission sculpt neuronal circuits, and provide the initial configuration of connections
necessary for function and survival. It is well established that neurosteroids regulate
synaptic transmission by altering the function of pre and/or postsynaptic neurotransmitter
receptors.

1.2.3 Steroids and Development
Steroids are cholesterol metabolites with a core structure formed by four
cycloalkane rings (Figure 1.4). The synthesis of these compounds starts with the
translocation of cholesterol from the outer to the inner mitochondria membrane, by the
steroidogenic acute regulatory protein (StAR). Then, cholesterol is transformed into
pregnenolone by virtue of the cytochrome P450 side-chain cleavage enzyme (P450scc).
Pregnenolone is the precursor to other steroids (Figure 1.4). Steroids have been long
recognized to modulate development and, in fact, have been shown to be essential.
Disruption of steroid production in P450scc knockout mice leads to death at P1-2.
However, steroid administration can rescue these mice (Hu et al., 2002).
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Figure 1.4. Synthesis of steroids. Adapted from Schumacher 2007 and Tsutsui 2008

Hormonal steroids organize the developing brain during a perinatal sensitive
period and have enduring consequences for adult behavior. In male rodents testicular
androgens are aromatized in neurons to estrogens and initiate distinct cellular processes
that ultimately determine the masculine phenotype. In brain regions such as the preoptic
area, the ventro-medial nucleus and the mediobasal hypothalamus, steroids modulate
mainly cell number and dendritic morphology. The mechanisms responsible for these
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effects include estradiol-induced modulation of prostaglandin synthesis, presynaptic
release of glutamate, postsynaptic changes in glutamate receptors, and changes in cell
adhesion molecules (reviewed in (Wright et al., 2010)).
Importantly, steroids synthesized de novo in the brain have also been shown to
play important roles during development. These steroids, locally synthesized in the brain,
are collectively called neurosteroids. Among these developmental regulators are
pregnenolone and its sulfated ester, progesterone, allopregnenolone, and DHEA and its
sulfate. These steroids have been shown to be involved in myelination, oligodendrocyte
differentiation, neurogenesis, neuroprotection, and neurite outgrowth (reviewed in
(Mellon, 2007)).

1.2.4 Neurosteroids influence PC development
The PC was the first neuronal cell type in the brain identified as
neurosteroidogenic. These cells express several kinds of neurosteroidogenic enzymes
such as StAR, P450scc, and 3β-hydroxysteroid dehydrogenase isomerase (3β-HSD),
starting in the neonatal period. Interestingly, the expression of P450scc appears
immediately after differentiation. PCs have been proposed to synthesize pregnenolone
and its sulfated ester, progesterone, and progesterone metabolites (Tsutsui et al., 2003).
Neuroactive steroids such as estradiol, allopregnanolone, and progesterone have been
shown to play a role in PC survival, dendritic growth, spine formation and
synaptogenesis (Sakamoto et al., 2001, 2002, Tsutsui et al., 2003, Griffin et al., 2004,
Sasahara et al., 2007).
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A morphological study showed that estrogen administration during neonatal life
resulted in dendritic growth, spinogenesis, and synaptogenesis in mouse PCs. Conversely,
decreases in endogenous estrogen, produced by knocking down the P450 aromatase
enzyme, led to the inhibition of dendritic growth, spinogenesis, and synaptogenesis.
These developmental effects were shown to be mediated by an estrogen-induced increase
in the expression of brain-derived neurotrophic factor (Sasahara et al., 2007).
Allopregnanolone has neuroprotective and neurogenesis-inducing effects (Mellon,
2007). In the cerebellum, allopregnanolone increases PC survival in a mouse model of
Niemann-Pick type C disease, an autosomal recessive, childhood neurodegenerative
disease characterized by defective intracellular cholesterol trafficking. In this model,
there is an age-dependent decrease in the ability to synthesize allopregnanolone.
Importantly, administration of allopregnanolone at P7-10 delays the onset of neurological
symptoms, such as ataxia and tremor, and increases PC survival (Griffin et al., 2004).
In cerebellar slice cultures from neonatal rats, progesterone increases the density
of PC dendritic spines, in a dose-dependent manner, via modulation of the nuclear
progesterone receptors A and B (Sakamoto et al., 2002). Similarly, an in-vivo study
showed that administration of progesterone to neonatal (P3-5) rats resulted in an increase
in the density of PC spine synapses (Sakamoto et al., 2001).
Although, the synthesis of other neurosteroids, such as pregnenolone and its
sulfate ester, in the developing PC, has been suggested, it is not clear whether these
participate in the maturation of synapses onto PCs. Work from our laboratory has
implicated a pregnenolone sulfate (PregS)-like neurosteroid as a modulator of synaptic
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transmission in the developing hippocampus. These studies showed that a retrogradely
released PregS-like neurosteroid enhances glutamate release onto CA1 pyramidal cells
via activation of presynaptic N-Methyl-D-aspartate (NMDA) receptors (Mameli et al.,
2005). Interestingly, the deleterious effects of ethanol on hippocampal development are
mediated in part by alterations in the production of this sulfated neurosteroid, which may
result in premature stabilization of excitatory synapses. Ethanol strengthens AMPA
receptor-mediated transmission in the CA1 region by reducing the failure rate of lowefficacy synapses. A PregS antibody scavenger and blockade of neurosteroid synthesis
prevents this effect of ethanol. A pharmacologically-induced increase in PregS
production, using a sulfatase inhibitor, mimicked alcohol’s effects (Mameli and
Valenzuela, 2006).
The development of PCs could be influenced by PregS via a mechanism of
retrograde release similar to the one found in the neonatal hippocampus (Mameli et al.,
2005). In addition, these cells could be exposed to systemically circulating PregS. Studies
have shown that maternal and fetal PregS levels in plasma are increased during
pregnancy and are highest during delivery. During midpregnancy, it has been shown that
PregS levels in the fetal blood serum is over 5 times higher than in serum from the
mother and in the amniotic fluid (Bicikova et al., 2002). Although, sulfated steroids are
believed not to be able to cross the blood brain barrier, it is possible that sulfated steroids
are transported inside cells and taken up from the blood through the blood brain barrier
via active transport processes. It has been shown that intravenously administered PregS
may cross this barrier without being hydrolyzed to the more lipophilic pregnenolone.
Also, sulfo-conjugated steroids have been shown to cross the sheep fetal blood brain
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barrier (Schumacher et al., 2008). Therefore, it is of interest to investigate the sensitivity
of the neonatal cerebellar cortex to PregS, as well as the possible roles of this
neurosteroid in the development of the cerebellar cortical circuitry.

1.3 Molecular targets of PregS.
Sulfated steroids and in particular, PregS, act on a wide range of synaptic
membrane receptors and/or ion channels, thereby rapidly modulating synaptic
transmission. They can act on presynaptic sites to modulate neurotrasmitter release and/or
on postsynaptic sites to modulate ion channels and neurotransmitter receptors, leading to
significant changes in neuronal excitability.
It has been shown that PregS can enhance currents through NMDA receptors (Wu
et al., 1991). However, NR2D-containing NMDA receptors expressed in Xenopus
oocytes are inhibited by this neurosteroid (Malayev et al., 2002, Jang et al., 2004). PregS
also act at GABAA and glycine receptors were it exerts an inhibitory effect (Wu et al.,
1990, Wu et al., 1997). PregS-mediated potentiation of α7 nicotinic acetylcholine
receptors, α1 receptors, voltage-gated Ca2+ channels, metabotropic σ1 receptors, and the
inwardly rectifying potassium (Kir) channel 2.3 has also been suggested (Meyer et al.,
2002, Chen and Sokabe, 2005, Dong et al., 2005, Hige et al., 2006, Monnet and Maurice,
2006, Kobayashi et al., 2009). In addition, PregS inhibits kainate and AMPA receptors
(Wu et al., 1991).
Recently, it has been shown that certain members of the superfamily of transient
receptor potential (TRP) channels are sensitive to PregS. The capsaicin receptor (the
TRPV1 vanilloid channel) was shown to be inhibited by PregS in dissociated dorsal root
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ganglion neurons. These results postulated PregS as a pharmacological agent for the
reduction of reducing capsaicin receptor-mediated nociception (Chen and Wu, 2004).
PregS-induced activation of TRPM3 melastatin receptors has been demonstrated in
TRPM3-expressing human embryonic kidney and pancreatic β cells (Wagner et al.,
2008). Interestingly, TRPM2, TRPM7, TRPM8, TRPV4, and TRPV6 were found to be
insensitive to PregS (Wagner et al., 2008). Additionally, TRPC channels have been
suggested to mediate the PregS-induce increase in glutamate release at dentate gyrus hilar
neurons and perhaps also PCs; however, the involvement of a specific TRPC channel in
this effect and direct activation by PregS has not been reported (Lee et al., 2010,
Zamudio-Bulcock and Valenzuela, 2011).

1.3.1 Transient receptor potential channels as steroid receptors
The members of the superfamily of TRP channels share the common features of
six transmembrane segments, varying degrees of sequence homology, and permeability to
cations. However, they display a remarkable diversity of cation selectivities and specific
activation mechanisms. This diverse family of cation channels responds to various stimuli
such as temperature, mechanical stress, light, sound, osmolarity, and several endogenous
and exogenous chemical signals. It is believed that they act mainly by changing the
membrane potential and increasing intracellular Ca2+ (Venkatachalam and Montell,
2007). The TRP superfamily of cation channels contains approximately 50 members
expressed from yeast to human. It is divided into 7 subfamilies on the basis of structural
homology as follows, the TRPC ('Canonical') group, the TRPV ('Vanilloid') group, the
TRPM ('Melastatin') group, the TRPP ('Polycystin'), the TRPML ('Mucolipin'), the TRPA
('Ankyrin'), and the TRPN ('NOMP') family (Nilius and Voets, 2005).
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1.3.2 The steroid sensitive TRPM3 channel.
As mentioned above, TRPM3 channels have been recently found to be potently
enhanced by PregS (Wagner et al., 2008, Majeed et al., 2010, Klose et al., 2011). The
TRPM3 gene displays a highly conserved organization in mouse, rat, and human. In
mouse, this gene is located in chromosome 19b, contains 28 exons, and its size is about
850 kb (Oberwinkler et al., 2005b). The TRPM3 gene encodes the largest number of
variants within the TRP gene family. In mouse, five variants have been identified
(mTRPM3α1-5) and in human seven of them have been identified (hTRPM3 a-f and
hTRPM31325) (Oberwinkler and Phillipp, 2007). Interestingly, in intron 8 the TRPM3
gene hosts the gene for the microRNA, miR-204. Given that microRNAs induce
downregulation of genes very different from their host gene, miR-204 is not likely to
control the expression of TRPM3 in a direct autoregulatory manner (reviewed in
(Oberwinkler and Phillipp, 2007)); however, it could regulate other genes related to
TRPM3 function.
The TRPM3 protein features six transmembrane domains, a conserved TRP motif
and a coiled region in its C-terminus (Fig. 1.5). Additionally, it contains the characteristic
700 amino acid-long TRPM homology region in the N-terminal. Within the amino
terminus the TRPM3 protein contains four putative calmodulin-binding sites, suggesting
a Ca2+/calmodulin dependent regulation of these channels. However, such regulation is
yet to be tested (Oberwinkler and Phillipp, 2007). TRPM3 proteins assemble an ion
conducting channel. The permeability of this channel depends on the splice event in the
linker region between the transmembrane helices five and six. Thus, different splice
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variants are permeable to different ions (Grimm et al., 2003). In general the selectivity of
TRPM3 channels for Ca2+ is high (PCa:PNa = 1.6).

Figure 1.5. Transmembrane topology of TRPM3 and known sequences variations of TRPM3
resulting from alternative splice and transcription initiation processes (Hoffmann et al., 2010)

In TRPM3-expressing human embryonic kidney cells, TRPM3 forms a constitutively
active Ca2+ and Mn2+ permeable channel (Grimm et al., 2003). The spontaneous TRPM3
currents are enhanced by hypotonic extracellular solutions and cell swelling. TRPM3 can
also be activated by Ca2+ store depletion or sphingolipids (Venkatachalam and Montell,
2007). In addition TRPM3 channels carry outwardly rectifying and voltage-dependent
currents. However, the degree of rectification varies depending on the splice variant
(Grimm et al., 2003, Oberwinkler et al., 2005b). In humans, the highest expression of
TRPM3 has been found in kidney, brain, pituitary, ovaria, and pancreas. In the mouse,
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the brain is the main source of TRPM3 expression. The mouse brain regions where
TRPM3 has been detected include the dentate gyrus, lateral septal nuclei, indisium
griseum, tenia tecta, choroid plexus, corpus callosum, cerebellum, and brain stem
(Grimm et al., 2003, Hoffmann et al., 2010). However, the functional significance of
TRPM3 in the brain remains largely unknown.

1.4 Summary.
In the cerebellar cortex the first three postnatal weeks represent an active period of
synapse formation and stabilization. PCs are highly neurosteroidogenic sites throughout
development and the steroids progesterone, allopregnanolone, and estradiol have been
shown to modulate the morphological maturation of PCs and of developing synapses
(Tsutsui et al., 2003). PregS is a neuro-active steroid capable of rapidly affecting synaptic
transmission via modulation of membrane ion channels. This neurosteroid is known to
strengthen glutamatergic transmission in the neonatal hippocampus (Mameli et al., 2008).
However, despite its proposed presence in the developing PC, the role of PregS in PC
synapse development had not been explored.
The studies described in this dissertation characterize the effects of PregS in
neurotransmission in neonatal PCs and identify the steroid-sensitive TRPM3 channel as a
novel modulator of glutamatergic transmission in the developing brain.
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2. Goals of this study
Specific Aim 1. Do PregS-like neurosteroids modulate neurotransmission in
developing Purkinje cells?
Neuroactive steroids have been shown to play an important role in processes such
as learning and memory and maturation of brain circuits (Grobin and Morrow, 2001).
They modulate synaptic transmission by acting on a wide range of synaptic membrane
ion channels and regulate the excitatory/inhibitory balance in the brain. The neuroactive
steroid pregnenolone sulfate (PregS), in addition to modulating synaptic transmission in
the adult brain (Chen and Sokabe, 2005, Schiess and Partridge, 2005, Monnet and
Maurice, 2006) has also been shown to potentiate glutamatergic transmission in the
immature hippocampus (Mameli et al., 2005). Another brain region that could be targeted
by PregS during development is the cerebellum. The cerebellar Purkinje cell (PC) is an
active neurosteroidogenic cell, which expresses the cholesterol side chain cleavage
enzyme, P450scc, in adulthood and neonatal life. P450scc synthesizes pregnenolone from
cholesterol (Ukena et al., 1998). Therefore, we investigated whether PregS affected
GABAergic and/or glutamatergic transmission in developing PCs.

Specific Aim 2. What is the mechanism underlying the PregS-induced increase in
glutamate release onto neonatal Purkinje cells?
PregS has been shown to modulate glutamate release in various brain regions via
modulation of several targets such as σ1, α7 nicotinic acetylcholine, dopamine 1,
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adrenergic α 1 receptors, and transient receptor potential C channels (Baulieu et al., 2001,
Dong et al., 2005, Schiess and Partridge, 2005, Lee et al., 2010). In the immature
hippocampus, PregS acts via NMDA receptor activation. In these studies we
systematically tested the involvement of known PregS targets as well as modulators of
glutamatergic transmission in the developing cerebellum, on the PregS-induced increase
in glutamate release at immature PCs.
Specific Aim 3. Does the PregS-induced increase in glutamatergic transmission
modulate the development of climbing fiber - and/or parallel fiber-to-Purkinje cell
synapses?
Using acute slice preparations we were able to characterize and elucidate the mechanism
by which PregS exerts its potentiating effects on glutamate release at developing PCs.
However, it is of interest to investigate whether endogenous PregS regulates the
development of glutamatergic synapses onto PCs. In these studies we used organotypic
cultures to investigate whether increasing the levels of endogenous PregS-like
neurosteroids during development could modulate glutamatergic transmission at
cerebellar PCs
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3. Pregnenolone Sulfate Increases Glutamate Release at Neonatal
Climbing Fiber-to-Purkinje Cell Synapses

Paula A. Zamudio-Bulcock and C. Fernando Valenzuela
Department of Neurosciences
University of New Mexico Health Sciences Center
Albuquerque, NM 87131, U.S.A.
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3.1 Abstract
Development of cerebellar Purkinje cells (PCs) is modulated by neuroactive
steroids. Developing hippocampal pyramidal neurons retrogradely release a pregnenolone
sulfate (PregS)-like neurosteroid that may contribute to glutamatergic synapse
stabilization. We hypothesized that PregS could exert a similar effect on developing PCs.
To test this hypothesis, we performed whole-cell patch-clamp recordings from PCs in
acute cerebellar vermis slices from neonatal rats. PregS induced a robust (~3,000 %) and
reversible increase in AMPA receptor-mediated miniature excitatory postsynaptic current
(AMPA-mEPSC) frequency without affecting the amplitude, time-to-rise, or half-width
of these events. PregS also increased the frequency of GABAA receptor-mediated
miniature postsynaptic currents, but to a significantly lesser extent (<100%). The PregSinduced increase of AMPA-mEPSC frequency was not significantly decreased by
antagonists of receptors (NMDA, glycine, α7 nicotinic acetylcholine, and σ1) that have
been shown to modulate glutamatergic transmission at PCs and/or mediate the actions of
PregS on neurotransmitter release. Ca2+ chelation experiments suggested that PregS acts
by increasing presynaptic terminal [Ca2+]i, an effect that is independent of voltage-gated
Ca2+ channels, but is blocked by the antagonist of transient receptor potential (TRP)
channels, La3+. PregS also increased the amplitude of EPSCs evoked by climbing fiber
(CF) stimulation and decreased the paired-pulse ratio of these events. Neither CF- nor
parallel fiber- evoked EPSCs were affected by PregS in slices from juvenile rats. These
results suggest that glutamate release at CF-to-PC synapses is an important target of
PregS in the neonatal cerebellar cortex, an effect that may play a role in the refinement of
these synapses.
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3.2 Introduction
The cerebellum is essential for motor coordination, motor learning, timing of
conditioned reflexes, and also for a number of higher cognitive functions (Ito, 2002).
Alterations in the function of neurons of the cerebellar cortex and deep cerebellar nuclei
have been implicated in the pathophysiology of several neurological and psychiatric
disorders, including autism, schizophrenia, alcoholism, fetal alcohol syndrome, and
ataxia (Schmahmann, 2004, Ito-Ishida et al., 2008, Shi et al., 2009). The mature
cerebellar cortex consists of three layers—the granule layer is the innermost layer, the
Purkinje layer is the middle layer and the molecular layer is the outermost layer. The
granule cell layer contains the cerebellar granule cells and Golgi cells. Cerebellar granule
cells receive excitatory input from the brain stem and spinal cord via mossy fibers and
inhibitory input from Golgi cells. The axons of granule cells form the parallel fibers (PFs)
that provide glutamatergic input to distal dendrites of Purkinje cells (PCs). PCs also
receive glutamatergic input from the inferior olive via the climbing fibers (CFs), which
synapse onto more proximal dendrites. γ-aminobutyric acid (GABA)- releasing
interneurons (i.e. basket and stellate cells) located in the molecular layer provide
inhibitory input to PCs; these cells are collectively known as molecular layer interneurons
(MLIs). PCs are GABAergic neurons that project to deep cerebellar nuclei and their
axons constitute the only output of the cerebellar cortex.
PCs undergo marked morphological and functional changes during the first 2
postnatal weeks in rodents; the first 10-12 days of life in rats is equivalent to the 3rd
trimester of pregnancy in humans and is a critical period for PC maturation. During this
period, PCs merge into a single layer, develop an extensive dendritic tree, and form
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synaptic connections (Kurihara et al., 1997, Eilers et al., 2001). The development of CFto-PC synapses precedes that of PF-to-PC synapses. CF-to-PC synapses have been
detected as early as embryonic day (E) 19 (Morara et al., 2001). From the onset of CF-toPC synaptogenesis until postnatal day (P) 4-7, the number of CF inputs per PC reaches a
maximum of approximately 5. These immature CF-to-PC inputs differ in synaptic
strength and decrease in number through the 3rd postnatal week by a process of synapse
elimination of all but the strongest CF input (reviewed in (Bosman and Konnerth, 2009).
In immature neurons, glutamatergic and GABAergic transmission have been
shown to regulate the maturation of dendrites and axons, as well as synaptogenesis and
synaptic refinement. Glutamate controls dendritic arbor growth via N-methyl-D-aspartic
acid (NMDA) receptor-dependent Ca2+ transients and insertion of α-amino-3-hydroxyl-5methyl-4-isoxazole-propionate (AMPA) receptors (Cline and Haas, 2008). GABA acts
mainly by binding to GABAA receptors, which conduct Cl- ions out of developing
neurons, leading to membrane potential depolarization and activation of voltage-gated
Ca2+ channels. This is in contrast to GABAA receptors in mature neurons where Cl- flows
into the cell, causing membrane potential hyperpolarization (Huang et al., 2007b).
Therefore, factors that modulate the glutamatergic and GABAergic neurotransmitter
systems in developing neurons can have an impact on synapse formation and maturation.
Among these factors are neuroactive steroids produced in the brain either from peripheral
precursors or independently of these precursors (i.e. neurosteroids) (Mellon, 2007).
Neurosteroids and neuroactive steroids such as allopregnanolone, progesterone, and
estradiol have been shown to play a role in PC survival, dendritic growth, spine
formation, and synaptogenesis (Tsutsui et al., 2003, Sasahara et al., 2007). However, it is

27

unknown whether other neurosteroids participate in the maturation of synapses onto PCs.
Work from our laboratory demonstrated that an endogenous pregnenolone sulfate
(PregS)-like neurosteroid produces a long-lasting strengthening of glutamatergic
transmission in developing CA1 hippocampal pyramidal neurons (Mameli et al., 2005).
Based on these results, we hypothesized that PregS also enhances glutamatergic synaptic
transmission at developing PC synapses. To test this hypothesis we used whole-cell
patch-clamp electrophysiological techniques in acute cerebellar slices from rats and
measured changes in glutamatergic transmission upon bath application of PregS. For
comparison, we also tested the effect of PregS on GABAergic transmission in immature
PCs.
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3.3 Experimental procedures
Unless specified, all chemicals were from Sigma (St. Louis, MO) or Tocris
Bioscience (Ellisville, MO). All experiments were approved by the University of New
Mexico Health Sciences Center Institutional Animal Care and Use Committee and
conformed with National Institutes of Health guidelines. Cerebellar vermis parasagittal
slices (250 µm-thick) were prepared from neonatal (P4-10) or juvenile (P15-21) SpragueDawley rats and recordings from PCs were performed, as previously described (Mameli
et al., 2008). The artificial cerebrospinal fluid (ACSF) was equilibrated with
95%O2/5%CO2 and contained the following (in mM): 126 NaCl, 2 KCl, 1.25 NaH2PO4,
1 MgSO4, 26 NaHCO3, 2 CaCl2, 10 glucose, and 10 μM SR 95531 or 1 μM GYKI 53655
for AMPA-mEPSC and GABAA-mPSC recordings, respectively. For these recordings the
membrane potential was held at -70 mV. For Ca2+ free recordings, the MgSO4
concentration was increased to 3 mM and 1 mM ethylene glycol tetraacetic acid (EGTA)
was added to reduce contaminant Ca2+ levels (Perez-Velazquez et al., 1994). Patch
pipette resistances were between 2 and 5.5 MΩ. AMPA-mEPSCs, GABAA-mPSCs and
CF stimulation- evoked EPSCs (CF-eEPSCs) were recorded from neonatal rat slices
using an internal solution containing (in mM): 150 CsCl, 1.5 MgCl2, 10 HEPES, 0.1
BAPTA (Calbiochem, La Jolla, CA), 2 Na2-ATP, 0.4 Na-GTP, at pH 7.3. For CF-eEPSC
and PF-eEPSC recordings from juvenile rat slices, the internal solution contained (in
mM): 120 CsOH, 120 D-gluconic acid, 3 tetraethylammonium-Cl, 10 HEPES, 0.1
BAPTA, 2 Na2-ATP, 2 Na-GTP and 0.2 Mg-ATP. The access resistance was between 10
and 30 MΩ. If the access resistance changed > 30%, the recording was discarded.
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Recordings of mPSCs were obtained in presence of 0.5 μM tetrodotoxin (TTX;
Calbiochem, La Jolla, CA).
For CF-eEPSC recordings, an ACSF-filled glass unipolar stimulating electrode
was used and was placed on the granule cell layer, ~ 150 μm from the PC. A pair of
current pulses, (duration of 100 μs; intensity 20-100 μA) was delivered every 15 s with
an inter-event-interval of 50 or 60 ms. The holding potential was -70 mV in neonatal rat
slices. In juvenile rat slices, the amplitude of the CF-eEPSC dramatically increased with
respect to that of neonatal rat slices. To improve voltage-clamp stability in juvenile rat
slices, the holding potential was therefore changed to -10 mV and the Ca2+ concentration
in the ACSF was lowered to 0.5 mM (Mg2+ concentration was increased to 2.5 mM). All
responses evoked were typical of CF-to-PC synapses, as they were all-or-none, and
showed paired-pulse depression. PF-eEPSCs were recorded from juvenile rat slices using
a holding potential of -50 mV or -70 mV. For these recordings, the stimulation electrode
was placed in the molecular layer (duration of 100 μs; intensity 20-100 μA). For all
stimulation experiments, 4 mM QX-314 bromide was added to the internal solution. The
paired-pulse ratio (PPR) was calculated as eEPSC2/eEPSC1.
Data were acquired with pClamp 9.2 or 10 (Molecular Devices, Sunnyvale, CA)
at a filtering frequency of 2 kHz and an acquisition rate of 10 kHz. Miniature events were
analyzed using Mini Analysis (Synaptosoft, Decatur, GA); only events that had an
amplitude at least eight times greater than the noise (average 0.84 ± 0.04 pA; n = 11)
were selected for analysis. Individual recordings were analyzed using the KolmogorovSmirnov (K-S) test using a conservative value for significance of p < 0.01. Evoked
EPSCs were analyzed with Clampex 9.2 (Molecular Devices, Sunnyvale, CA). Statistical
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analyses of pooled data were performed with GraphPad Prizm 4 (GraphPad Software,
San Diego, CA). Data were initially analyzed with the D’Agostino and Pearson omnibus
normality test.

If data followed a normal distribution, these were analyzed using

parametric tests. If this was not the case, then non-parametric tests were used. The level
of significance was p < 0.05. Data were normalized to baseline and expressed as percent
of baseline, or as change in Hz ± SEM.
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3.4 Results
3.4.1 PregS enhances the frequency but not the amplitude of AMPA-mEPSCs in neonatal
PCs
We tested the effect of PregS on AMPA-mEPSCs in neonatal rat (P4-10) slices.
These events were recorded in presence of the GABAA receptor antagonist, SR 95531 (10
μM) and, under these conditions, were completely blocked by the AMPA receptor
antagonist, GYKI 53655 (50 μM; n = 9; not shown). Fig 3.1A-C shows that bath
application of PregS (25 μM) for 5 min, reversibly enhanced AMPA-mEPSC frequency
without having an effect on amplitude. The effect of PregS on AMPA-mEPSC frequency
was robust (3,580 ± 1,073 % of baseline; p < 0.0001, n=21) (Fig 3.1C). K-S test analysis
revealed that the AMPA-mEPSC inter-event interval was significantly decreased in 21
out of 21 neurons, whereas the amplitude was increased in 5 out of 21 neurons, decreased
in 6 out of 21 and was not affected in 10 out of 21. The frequency of AMPA-mEPSCs (in
Hz) in the absence and presence of PregS is shown in Fig 3.1C and Table 3.1; PregS
increased the frequency of these events approximately 13-fold. The percent increase in
the frequency of these events was inversely correlated with the baseline frequency, while
the increase in Hz showed no correlation with the baseline frequency (Fig 3.1D). PregS
did not affect the AMPA-mEPSC time-to-rise (107 ± 4.6 % of baseline) or half-width
(102 ± 2.8 % of baseline) (not significant by Wilcoxon Signed Rank Test; n = 21) (Table
3.1). We also tested the effect of a lower concentration of PregS (5 μM) on the frequency
of AMPA-mEPSCs and found that it significantly enhanced AMPA-mEPSC frequency
(401.1 ± 114.7 % of baseline; raw change from baseline 0.6 ± 0.26 Hz; n=4; the K-S test
showed a significant reduction in the inter-event interval in 3 out of 4 cells) without
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affecting amplitude, time-to-rise or half-width (data not shown). To determine whether
PregS had an effect on AMPA-mEPSC frequency in slices from older animals, we
measured its effect at P12. Using a Cs-gluconate-based solution, we found that 25 µM
PregS significantly increased AMPA-mEPSC frequency, but to a lesser extent than in
PCs from P4-10 rats (184.3 ± 13.83 % of baseline; raw frequency change 0.97 ± 0.46 Hz;
n=4; KS test <0.01 in all 4 cells).

3.4.2 PregS enhances AMPA-mEPSC frequency independently of neurotransmitter
receptors.
PregS has been shown to modulate glutamate release onto immature as well as
mature neurons via modulation of a number of neurotransmitter receptors; namely,
NMDA, σ1, and α7 nicotinic acetylcholine receptors (α7nACh) (Meyer et al., 2002, Chen
and Sokabe, 2005, Mameli et al., 2005, Schiess and Partridge, 2005). In addition,
activation of NMDA and glycine receptors has been shown to facilitate transmitter
release onto developing PCs (Kawa, 2003, Bidoret et al., 2009). Previous findings in the
developing hippocampus suggested that PregS enhances glutamate release onto CA1
pyramidal neurons from neonatal rats via activation of presynaptic NMDA receptors
(Mameli et al., 2005). In cultured hippocampal neurons PregS enhances mEPSC
frequency via modulation σ1 receptors, and at perforant path-to-dentate granule cell
synapses, it produces a similar effect via modulation of α7nACh receptors (Kawa, 2002,
Meyer et al., 2002, Chen and Sokabe, 2005). Therefore, we measured the effect of PregS
on AMPA-mEPSCs in the presence of DL-2-Amino-5-phosphonopentanoic acid (DLAPV) (100 μM), strychnine (1 μM), BD-1063 (1 μM), and methyllycaconitine (MLA;
200 nM) to block NMDA, glycine, σ1, and α7nACh receptors, respectively. In the
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presence of these agents, PregS increased AMPA-mEPSC frequency to a similar extent
as under control conditions (Fig 3.2). The K-S test showed that PregS significantly
decreased the inter-event interval of AMPA-mEPSCs in all cells regardless of the
pharmacological blocker used. Basal AMPA-mEPSC properties were not significantly
affected by any of these agents (Table 3.1).

3.4.3 PregS enhances AMPA-mEPSC frequency by increasing presynaptic [Ca2+]i via
activation of a TRP channel
We next used the membrane-permeable Ca2+ chelator, BAPTA-AM (50 μM), to
test the role of Ca2+ in the mechanism of action of PregS. A 10 minute incubation with
BAPTA-AM, followed by a 5 minute washout, resulted in no significant change in basal
AMPA-mEPSC frequency (Table 3.1) and a significant reduction of the PregS-induced
increase of AMPA-mEPSC frequency (565.2 ± 379 % of baseline, **p < 0.05; raw
frequency change of 0.65 ± 0.3 Hz from baseline, ***p <0.05, Fig 3.3) when compared to
controls (2,824 ± 1,014 % of baseline; raw frequency change 11.41 ± 1.82 Hz from
baseline, Fig 3.3B). It is noteworthy that, with this treatment, the K-S test showed that, 5
out of 9 cells showed no significant change in the AMPA-mEPSC inter-event interval
with PregS bath application, and the remaining 4 showed a significant decrease. BAPTAAM is expected to non-selectively chelate Ca2+ both in the pre- and post-synaptic
compartments. To determine whether PregS acts by selectively increasing Ca2+ in one of
these compartments, we tested the effect of postsynaptic Ca2+ chelation by dialyzing
BAPTA (10 mM) into PCs through the patch pipette. The K-S test showed that in 3 out of
3 cells, PregS significantly enhanced the frequency of AMPA-mEPSCs (2,541 ± 864.4 %
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of baseline; raw frequency increase of 13.69 ± 7.15 Hz from baseline, n=3, data not
shown), suggesting that PregS acts by increasing [Ca2+]i in presynaptic terminals.
To further assess if Ca2+ entrance into the presynaptic terminal was required for
this effect of PregS, we performed experiments in Ca2+ free ACSF in the presence of the
Ca2+ chelator, EGTA (1mM); under these conditions, the baseline AMPA-mEPSC
frequency (0.25 ± 0.11 Hz) was not significantly different from control (p> 0.05 by
unpaired t-test, n=4; see Table 3.1 for control values) and the K-S test showed that in 4
out of 4 cells PregS did not significantly change the AMPA-mEPSC inter-event interval
(132.6 ± 28.01 % of baseline, not significant by Wilcoxon Signed Rank Test; raw
frequency change of 0.027 ± 0.043 Hz from baseline, n=4, data not shown).
At calyx of Held developing synapses, PregS was shown to increase glutamate
release via facilitation of voltage-gated Ca2+ channels (VGCCs) (Hige et al., 2006). To
test the involvement of these channels in the effect of PregS on neonatal PCs, we
performed recordings in the presence of Cd2+ (100 μM), a broad spectrum VGCC
antagonist. As shown in Table 3.1, Cd2+ did not significantly change basal AMPAmEPSC parameters. Moreover, in the presence of Cd2+, PregS potently increased the
frequency of AMPA-mEPSCs (2,064 ± 458.30 % of baseline with a raw frequency
increase of 17.18 ± 4.53 Hz, n= 11 , Fig 3.3), suggesting that VGCC are not involved in
this effect.
Recently, transient receptor potential (TRP) cation channels have been shown to
be modulated by PregS, which results in increases in [Ca2+]i (Wagner et al., 2008, Lee et
al., 2010). Therefore, we tested the effect of La3+, a blocker of a number of TRP channel
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subtypes (Albert et al., 2006). A 30 min incubation with La3+ (100 μM) did not
significantly decrease baseline AMPA-mEPSC frequency (Table 3.1). Taken together
with the lack of an effect of BAPTA-AM and Ca2+-free ACSF on basal mEPSC
frequency, this result suggests that if tonic levels of PregS are present at CF-to-PC
synapses, these are not sufficiently high to support quantal glutamate release, in
agreement with our previous finding that a significant level of neuronal activity is
required for retrograde release of endogenous PregS-like neurosteroids (Mameli et al.,
2005). However, after incubation with La3+, PregS did not significantly increase AMPAmEPSC frequency (152.2 ± 48.07 % of baseline; raw frequency change of -0.0021 ± 0.13
Hz, n= 11, Fig 3.3), suggesting that PregS increases AMPA-mEPSC frequency via
modulation of a TRP channel.

3.4.4 PregS increases PPR at CF-to-PC synapses in neonatal rat slices but does not affect
PPR in CF- and PF-to-PC synapses in juvenile rat slices.
During the neonatal period in rats, CFs are the major glutamatergic input to PCs,
with PF connections beginning to arrive after the first postnatal week (Bosman and
Konnerth, 2009, Cesa and Strata, 2009). To determine whether PregS enhanced AMPAmEPSC frequency by potentiating glutamate release at CF-to-PC synapses, we measured
paired-pulse plasticity of CF-eEPSCs in neonatal PCs. These evoked responses were
abolished in the presence of the AMPA receptor blocker, GYKI 53655 (50 μM). We
found that CF-eEPSC1 amplitude was significantly increased to 135.5 ± 2.43 % of
control, from a baseline value of 1,262 ± 258.8 pA (p < 0.001 vs 100%; n=10) in the
presence of PregS (25 μM) and this effect was partially reversible (Fig 3.4). Increases in
the probability of transmitter release are typically associated with decreases in the PPR.
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We found that PregS induced a significant and reversible decrease in the PPR to 75.87 ±
2.31 % of control, from a baseline value of 0.39 ± 0.03 (p < 0.001 vs 100%; n = 10). This
finding suggests that PregS increases glutamate release probability at CF-to-PC synapses.
CF mono-innervation is achieved during the first three postnatal weeks, during
which CF-to-PC synapses undergo three distinct developmental phases. During the first
postnatal week, multinumerary CF synapses onto one PC, which are composed of a
strong CF synapse and several weaker ones, become functionally differentiated. This
process is thought to be achieved via competition among CF inputs and is followed by an
early phase and a late phase of synapse elimination of redundant inputs, the last one being
dependent on PF-to-PC synapse formation (Kano and Hashimoto, 2009). We next
investigated whether PregS also enhanced glutamate release from CFs beyond the
functional differentiation phase (i.e. during the first week) and the early phase of synapse
elimination (i.e. during P7-12). To this end, we performed paired-pulse stimulation
recordings of CF-eEPSCs in juvenile rat slices (P15-21) and found that PregS (25 μM)
did not significantly affect the PPR of these events (baseline PPR was 0.42 ± 0.04; Fig
3.5). The amplitude of CF-eEPSC1 also remained unchanged in the presence of PregS.
These results suggest that PregS increases glutamate release probability at the CF-to-PC
synapse only during the phases of functional differentiation and early synapse
elimination.
We also tested whether PregS affected glutamate release at PF-to-PC synapses,
which start forming at the end of the first postnatal week, continuing their development
through the end of the third postnatal week when the migration of granule cells is
completed and the outer granule cell layer disappears (Kurihara et al., 1997, Scelfo and
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Strata, 2005). To this end, we recorded paired-pulse plasticity of PF-eEPSCs in juvenile
rat slices. We found that PregS did not change the amplitude or the PPR of PF-eEPSCs
(Fig 3.6), suggesting that the effect of PregS on glutamate release is specific to
developing CF inputs.

3.4.5 PregS also increases GABA release in developing PCs but to a lesser extent than
glutamate release.
For comparison, we investigated the effect of PregS on GABAergic transmission at PCs.
PregS has been shown to decrease the frequency of spontaneous inhibitory PSCs (IPSCs)
as well as mIPSCs in cultured pyramidal hippocampal neurons (Teschemacher et al.,
1997, Mtchedlishvili and Kapur, 2003), but it has been suggested to increase spontaneous
IPSCs in PCs (Tsutsui and Ukena, 1999). We found that PregS (25 μM) also enhanced
the frequency of GABAA-mPSCs in neonatal rat slices (183.9 ± 28.37 % of baseline, with
a raw frequency increase of 0.84 ± 0.33 Hz from baseline, n=10; p < 0.001 by one sample
t-test; the K-S test revealed that 6 out of 10 cells showed an statistically significant
decrease in GABAA-mPSC inter-event interval) (Fig 3.7; Table 3.2). In addition, PregS
significantly decreased the amplitude of these events (80.88 ± 5.35 % of baseline, p <
0.05 by one sample t test; raw amplitude decrease 18.52 ± 6.17 pA from baseline) (Table
3.2). Time-to-rise (99.86 ± 2.98 % of baseline), and half-width (97.66 ± 2.69 % of
baseline) were not significantly affected by PregS application (Table 3.2).
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3.5 Discussion
3.5.1 PregS enhances quantal glutamate release onto neonatal cerebellar PCs
A miniature postsynaptic current is produced by the opening of postsynaptic
neurotransmitter receptors in response to the presynaptic release of individual quanta of
neurotransmitter. Therefore, increases in the frequency of these events, are indicative of
an increase in presynaptic neurotransmitter release. On the other hand, changes in the
amplitude, time-to-rise, or half-width of miniature postsynaptic currents suggest an
alteration in the current through postsynaptic neurotransmitter receptors and are,
therefore, indicative of a postsynaptic change. We report here that, in neonatal PCs,
PregS increases the frequency of AMPA-mEPSCs, but does not affect the amplitude,
time–to-rise, or half-width of these events, indicating that it acts presynaptically by
increasing the release of glutamate onto PCs. This effect was observed at concentrations
of PregS (5 and 25 μM) that have been previously shown to increase quantal glutamate
release and are near the estimated concentration of an endogenous PregS-like
neurosteroid in glutamatergic synapses of developing CA1 pyramidal neurons (i.e., 17
μM); (Meyer et al., 2002, Dong et al., 2005, Mameli et al., 2005, Hige et al., 2006, Lee et
al., 2010). To the best of our knowledge, the PregS effect at PC glutamatergic
transmission shown here is the most robust action of this agent on quantal transmitter
release reported to-date. Previous studies have shown that 25 μM PregS increases
mEPSC frequency in developing hippocampal synapses by about 400% (Mameli et al.,
2005), and in the mature prelimbic cortex, a similar concentration of PregS (20 µM)
enhanced mEPSC frequency by about 200% (Dong et al., 2005). Moreover, the effect of
PregS on glutamatergic transmission in PCs was reversible, in contrast to its effect on
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immature CA1 pyramidal neurons, suggesting that the late postsynaptic phase of the
PregS-induced plasticity—that involves NMDA receptor-dependent recruitment of
AMPA receptors into silent syapses in CA1 pyramidal neurons— does not take place in
PCs (Mameli et al., 2005). A possible explanation for this finding is that postsynaptic
NMDA receptors in developing PCs have different characteristics, which make them
unable to recruit AMPA receptors into the membrane in response to changes in glutamate
release.

3.5.2 The PregS-induced increase of quantal glutamate release onto PCs is independent of
activation of neurotransmitter receptors
Another unique property of the effect of PregS at PCs is that it was insensitive to
blockade of a number of receptors (NMDA, glycine, α7nACh, and σ1 receptors), which
have been previously shown to mediate PregS effects and/or modulate neurotransmitter
release onto neonatal PCs. Although activation of NMDA receptors mediates the PregSinduced increase in glutamate release in neonatal hippocampal neurons (Mameli et al.,
2005), this is not the case in the neonatal cerebellum. Postsynaptic NMDA receptors have
been shown to contribute to CF-EPSCs before P21 (Piochon et al., 2007); however,
presynaptic NMDA receptors may not be present at neonatal CF-to-PC synapses and this
could be an explanation for their lack of contribution to the mechanism of action of
PregS. An alternative target of PregS that we considered was the glycine receptor, which
has been shown to enhance the frequency of spontaneous EPSCs and IPSCs in neonatal
PCs (Kawa, 2003). Nonetheless, in the presence of strychnine, the PregS-induced
increase in AMPA-mEPSC frequency was not affected. These results are not surprising
given that the glycine-induced increase in sEPSC frequency was almost completely
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abolished by TTX (Kawa, 2003), and that PregS has been shown to inhibit recombinant
glycine receptors (reviewed in (Gibbs et al., 2006). Another plausible candidate for the
effect of PregS on PCs was the Ca2+ permeable α7nACh receptor. This receptor has been
shown to modulate the PregS-induced facilitation of synaptic transmission in the
hippocampus (Chen and Sokabe, 2005). In addition, acetylcholine increases spontaneous
EPSC and IPSC frequency in developing PCs (Kawa, 2002). We found that blockade of
α7nACh receptors did not affect the PregS-induced increase in AMPA-mEPSC
frequency. PregS has also been shown to modulate glutamate release via activation of
metabotropic σ1 receptors. PregS-induced modulation of σ1 receptors enhances
facilitated glutamate release in the mature hippocampus (Schiess and Partridge, 2005),
and increases spontaneous glutamate release in cultured hippocampal neurons (Meyer et
al., 2002). We found that blockade of σ1 receptors did not abolish the effect of PregS in
PCs. Moreover, the σ1 receptor agonist, pre-084 did not affect AMPA-mEPSC frequency
in P9-12 PCs (n=4, data not shown), suggesting that these receptors do not play a role in
the spontaneous release of glutamate onto neonatal PCs. Taken together, these findings
indicate that NMDA, glycine, α7nACh, and σ1 receptors are not involved in the
mechanism of action PregS at neonatal PCs.

3.5.3 The PregS-induced increase of quantal glutamate release requires an elevation in
presynaptic [Ca2+]i and is dependent on activation of TRP channels
Previously, PregS-induced increases in glutamate release have been shown to be
dependent on elevations in [Ca2+]i; incubation with the membrane permeable Ca2+
chelator, BAPTA-AM, blocked the PregS-induced increase of AMPA-mEPSC frequency
in developing hippocampal neurons (Meyer et al., 2002, Mameli et al., 2005). Consistent
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with these studies, we found that pre-incubation with BAPTA-AM (50 µM), followed by
a 5 minute washout of BAPTA-AM before PregS bath application, dramatically
decreased the PregS-induced increase of AMPA-mEPSC frequency. However, this
treatment did not completely abolish the effect of PregS on neonatal PCs, which could be
explained by incomplete Ca2+ chelation. Absence of extracellular Ca2+ abolished the
PregS-induced increase in AMPA-mEPSC frequency in neonatal PCs. This result,
combined with the fact that dyalizing BAPTA into the PCs through the patch pipette did
not block the increase in mEPSC frequency, supports the conclusion that elevation in
Ca2+ entrance into the presynaptic terminal is required for this effect of PregS.
We found that the PregS-induced increase in AMPA-mEPSC frequency is
blocked by La3+. This finding is in agreement with the results of a recent study showing
that PregS increases sEPSC frequency in dentate gyrus hilar neurons, an effect that was
blocked by non-selective TRP channel antagonists, including La3+ (Lee et al., 2010). La3+
antagonizes several members of the canonical (C) family of TRP channels (TRPC3, 5, 6,
and 7) (Albert et al., 2006), suggesting that PregS could act by potentiating these
channels.

TRPC channels have been found to be expressed in presynaptic nerve

terminals (Goel et al., 2002, Nichols et al., 2007) and their activation has been implicated
in neurotransmitter release modulation (Selvaraj et al.). Interestingly, in the cerebellum,
the expression of TRPC channels has been shown to be developmentally regulated;
during the first 6 postnatal weeks, TRPC3 is abundantly expressed in comparison to
TRPC4 and TRPC6 channels (Huang et al., 2007a). Additionally, TRPC3 channels
mediate mGluR1-dependent slow EPSCs in PCs from young mice whereas TRPC1
channels mediate these currents in PCs from older animals (Kim et al., 2003, Hartmann et
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al., 2008). Given that the effect of PregS on glutamate release at PCs is restricted to the
neonatal period, it is possible that the loss of PregS sensitivity in more mature neurons is
a consequence of a change in the subunit composition of cerebellar TRPC channels.
An alternative TRP channel that could mediate the effects of PregS is TRPM3
(Kraft and Harteneck, 2005). PregS was shown to activate both recombinant TRPM3
channels expressed in HEK 293 cells and also native TRPM3 channels expressed in
pancreatic β cells and vascular smooth muscle, where PregS stimulates insulin secretion
and contraction, respectively (Wagner et al., 2008, Naylor et al., 2010). La3+ has been
shown to antagonize recombinant TRPM3 channels expressed in HEK 293 cells (Grimm
et al., 2003). Importantly, TRPM3 channels were recently found to be expressed in
developing neurons of the cerebellum and brain stem of Wistar rats. Interestingly, as
development progresses, expression of these channels becomes restricted to
oligodendrocytes (Hoffmann et al., 2010) and this could explain the lack of PregS
sensitivity of PCs in slices from juveniles rats. Clearly, the role of TRPM3 channels in
the mechanism of action of PregS in the developing cerebellum should be further
investigated.

3.5.4 PregS enhances glutamate release evoked by electrical stimulation of CFs in slices
from neonatal rats.
The all-or-none responses produced by CFs on mature PCs are mediated by a
massive release of glutamate that nearly saturates the postsynaptic AMPA receptors
(Konnerth et al., 1990). Therefore, at these synapses, an increase in glutamate release
probability would not be expected to dramatically increase CF AMPA-eEPSC amplitude
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(Ohtsuki and Hirano, 2008). Accordingly, the effect of PregS on AMPA-eEPSCs was
substantially smaller than on AMPA-mEPSCs. Interestingly, we found that the effect of
PregS on the probability of glutamate release at PCs is specific to CF synapses during the
neonatal period (i.e. P4-10), where CF-to-PC synapses undergo differentiation and the
first stages of elimination; importantly, PregS did not significantly affect glutamatergic
transmission at CF-to-PC synapses (and also PF-to-PC synapses) beyond these
developmental period (i.e. in slices from P15-21 rats). Thus, during this restricted
developmental period, PregS could act on CF-to-PC synapses to strengthen glutamatergic
transmission. Studies from our laboratory have shown that a PregS-like neurosteroid can
be retrogradely released upon depolarization of hippocampal CA1 pyramidal cells, which
subsequently increases glutamate release onto these cells (Mameli et al., 2005). In a
similar fashion, CF-induced depolarization of neonatal PCs could stimulate the retrograde
diffusion of a PregS-like neurosteroid, which in turn would increase the probability of
glutamate release at CF terminals via activation of TRP channels, thereby contributing to
the maturation of these synapses. It is important to note that the CF-eEPSC evaluated in
this study were the largest ones found in each cell, representing the responses of both
weak and strong CF inputs. Previous studies have shown that strong and weak CF
synapses differ in their response to stimulation; while strong CF synapses undergo long
term potentiation, under the same stimulation paradigm, weak CF synapses undergo long
term depression (Bosman et al., 2008, Ohtsuki and Hirano, 2008). Therefore, future
studies should investigate whether PregS differentially modulates the probability of
glutamate release and plasticity in strong versus weak CF-to-PC synapses and how this
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modulation affects CF synaptic competition and the subsequent achievement of
monoinnervation.

3.5.5 PregS increases GABAergic transmission onto neonatal PCs
We found that PregS significantly enhanced the frequency and decreased the
amplitude of GABAA-mPSCs. Our findings are in contrast with previous results showing
that PregS decreases GABAA-mPSC frequency in hippocampal neurons, suggesting a
decrease in GABA release upon PregS application (Teschemacher et al., 1997,
Mtchedlishvili and Kapur, 2003). Both of these studies were performed in cultured
hippocampal neurons (3-9 week in vitro) that were obtained from late embryonic or
neonatal rats, where it was found that PregS reduced the frequency of mIPSCs by 20 to
40% at concentrations between 30 nM and 50 μM (Teschemacher et al., 1997,
Mtchedlishvili and Kapur, 2003). The discrepancy between the previous studies and our
current findings could be due to differences in presynaptic release mechanisms, and their
sensitivity to PregS, in hippocampal neurons vs. PCs. During the first postnatal week,
GABAA receptors are excitatory and have been suggested to contribute to the activitydependent maturation of cerebellar synapses, including those of CFs (Eilers et al., 2001,
Watt et al., 2009). Therefore, the PregS-induced enhancement of GABAergic
transmission during this developmental period could play a role in the maturation of
GABAergic as well as glutamatergic synapses onto PCs. However, the specific source for
the PregS-sensitive GABA release sites remains undetermined, as molecular layer
interneurons to PC synapses start developing at the end of the first postnatal week (Ango
et al., 2004). A plausible candidate is the PC axonal collaterals to neighboring PCs, which
have been detected as early as P4 (Watt et al., 2009).
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The PregS-induced decrease in the amplitude of GABAA-mPSCs is in agreement
with previous reports showing that PregS inhibits GABAA receptor-mediated currents
(Akk et al., 2001). However, Mtchedlishvili and Kapur, (2003) found no effect of PregS
on the amplitude of GABAA mediated events and Teschemacher et al., (1997) reported a
non-reversible 15% decrease in the amplitude of mIPSCs upon PregS application. This
effect, however, was not attributable to a PregS- induced decrease in GABAA receptor mediated currents, because of its late onset and lack of concentration dependency, and
was better explained by current run-down. Our finding that the effect of PregS on
GABAA-mPSC amplitude is reversible (see Fig. 3.7B) suggests that PregS could directly
inhibit postsynaptic GABAA receptors.

3.6 Conclusion
Cerebellar PCs are highly neurosteroidogenic cells. The cytochrome P450scc,
which catalyzes the conversion of cholesterol to the neurosteroid precursor pregnenolone,
has been found in the soma and dendrites of PCs in rodents, avians, amphibians and other
lower vertebrates. This enzyme appears in rat PCs immediately after their differentiation
(reviewed in (Tsutsui and Ukena, 1999). Therefore, it is possible that PCs synthesize an
endogenous counterpart of PregS, which could play a role in the maturation of CF-to-PC
synapses (for a detailed discussion on whether PregS per se is a veritable neurosteroid,
see (Dong et al., 2005, Schumacher et al., 2008, Valenzuela et al., 2008). Importantly,
PCs are highly sensitive to developmental ethanol exposure (Servais et al., 2007) and
studies from our laboratory have shown that chronic prenatal ethanol exposure increases
the levels of PregS-like neurosteroids in the developing brain and that ethanol increases
the efficacy of immature hippocampal synapses in a PregS-like neurosteroid-dependent
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manner (Caldeira et al., 2004, Mameli et al., 2005, Mameli and Valenzuela, 2006,
Valenzuela et al., 2008). Therefore, alterations in the developmental actions of PregS at
PCs may play a role in the pathophysiology of the cerebellar alterations that characterize
fetal alcohol spectrum disorders.
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3.7 Figure Legends

Figure 3.1. PregS (25 μM) robustly increases the frequency of AMPA-mEPSCs in
PCs from neonatal rats. (A) Sample traces for a P5 rat, calibration: 20 pA, 0.2 s. Low
panel average events, calibration: 4.1 pA, 3 ms. (B) Corresponding cumulative
probability plots; PregS decreased the inter-event interval ( p < 0.01 by K–S test; 86
events/3 min before PregS and 2050 events/3 min during PregS); the inset further
illustrates the robust increase that PregS induces on the inter-event interval at an
expanded scale. The bottom panel shows that amplitude of these events is not
significantly affected by PregS. (C) Average time courses of AMPA-mEPSC frequency
and amplitude expressed as a percent of baseline (top panel) and as the raw change
(bottom panel) (n=21). (D) The percent increase in frequency induced by PregS is
inversely correlated to the baseline frequency (r = -0.7390; p < 0.05 by Spearman
correlation test, n=21) (top panel). However, the PregS-induced increase in frequency in
Hz is not correlated to the baseline frequency (r=-0.09775; p=0.6734 by Pearson
correlation test) (bottom panel).

Figure 3.2. The PregS (25 μM)-induced increase in AMPA-mEPSC frequency is
independent of NMDA, glycine, σ1, or α7nACh receptors. (A) Sample traces
illustrating the PregS effect on AMPA-mEPSC frequency in PCs from P4-5 rats in the
presence of the NMDA and glycine receptors blockers, DL-AP5 (100 μM) and strychnine
(1 μM); the σ1 receptor blocker, BD-1063 (1 μM); and the α7nACh receptor blocker,
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MLA (200nM); calibration: 50 pA and 0.2 s. (B) Summary graphs of the percent
frequency (left panel) and the raw frequency increases (right panel) induced by PregS in
the presence of NMDA, glycine, σ1 or α7nACh receptor antagonists. For both, percent
and raw frequency increases, one-way ANOVA followed by Dunn's multiple comparison
test showed no significant difference between controls (n=11) and DL-APV/strychnine
(n=11), BD-1063 (n=9) or MLA (n=10). The effect of PregS on AMPA-mEPSC
frequency from Fig 1 is shown again for comparison.

Figure 3.3. PregS (25 μM) increases AMPA-mEPSC frequency by elevating [Ca2+]i
possibly via modulation of TRP channels. (A) Sample traces illustrating the effect of
PregS on AMPA-mEPSC frequency in PCs from P4-5 rats in the presence of BAPTAAM, Cd2+ and La3+, calibration: 50 pA and 0.2 s. (B) Summary graphs of the percent
frequency (left panel) and the raw frequency (right panel) changes induced by PregS in
the presence of these agents. For both, percent and raw frequency increases, one-way
ANOVA followed by Dunn's multiple comparison test showed a significant difference
between controls (n=11), BAPTA-AM (n=9; * p < 0.05) and La3+ (n=11; *** p < 0.001).
The effect of PregS on AMPA-mEPSC frequency from Fig 1 is shown again for
comparison.

Figure 3.4. PregS (25 μM) increases CF-eEPSC amplitude and decreases the PPR in
PCs from neonatal rats. (A) Sample traces from a P6 rat, calibration: 500 pA, 50 ms.
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(B) Average time course of the effect of PregS (25 μM) on the amplitude on CF-eEPSC1
and PPR (n=10).

Figure 3.5. PregS (25 μM) does not affect CF-eEPSC amplitude or the PPR in PCs
from juvenile rats. (A) Sample traces from a P15 rat, calibration: 100 pA, 50 ms. (B)
Average time course of CF-eEPSC1 amplitude and PPR (n=7).

Figure 3.6. PregS (25μM) does not affect PF-eEPSC amplitude or the PPR in PCs
from juvenile rats. (A) Sample traces from a P18 rat, calibration: 200 pA, 20 ms. (B)
Average time course of PF-eEPSC1 amplitude and PPR (n=6).

Figure 3.7. PregS (25μM) increases the frequency of GABAA-mPSCs in PCs from
neonatal rats (A) representative traces from a P6 rat. Calibration: 50 pA, 1 s. Right panel
average events, calibration: 20.5 pA, 4 ms. (B) Time courses of the PregS- induced
changes of GABAA-mPSC frequency and amplitude.
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3.8 Tables
Table 3.1. AMPA-mEPSC parameters in PCs from neonatal rats in the absence and
presence of PregS or pharmacological receptor blockers.
*** p<0.01 vs. control by one-way ANOVA followed by Dunn’s multiple comparison
test.
Experimental
condition (n)

Frequency
(Hz)

Amplitude
(pA)

Time-to-rise
(ms)

Half-Width
(ms)

Control (11)

0.80 ± 0.22

23.20 ± 1.55

2.27 ± 0.12

1.98 ± 0.12

APV +
Strychnine (11)

0.81 ± 0.16

24.71 ± 1.68

2.93 ± 0.39

2.23 ± 0.14

BD1063 (9)

0.49 ± 0.14

20.16 ± 1.19

2.54 ± 0.25

2.18 ± 0.13

MLA (10)

0.31 ± 0.10

23.44 ± 2.72

2.69 ± 0.28

2.13 ± 0.24

BAPTA-AM (9)

0.66 ± 0.31

21.36 ± 1.46

2.79 ± 0.42

2.56 ± 0.3

PregS (11)

12.2 ± 1.98 ***

22.62 ± 1.50

2.59 ± 0.20

2.07 ± 0.15

Cd2+ (11)

1.79 ± 0.58

20.75 ± 1.52

2.08 ± 0.20

2.08 ± 0.16

La3+ (11)

0.44 ± 0.17

23.89 ± 2.69

2.05 ± 0.12

1.97 ± 0.15
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Table 3.2. GABAA-mPSC parameters in PCs from neonatal rats in the absence and
presence of PregS (25 μM).
* p < 0.05 by paired t-test,** p < 0.05 by Wilcoxon signed rank test.
Experimental
condition (n=10)

Frequency
(Hz)

Amplitude
(pA)

Time-to-rise
(ms)

Half-Width
(ms)

Control

1.88 ± 0.90

85.77 ± 10.35

2.79 ± 0.08

4.64 ± 0.23

2.72 ± 1.14 **

67.25 ± 7.54 *

2.78 ± 0.10

4.47 ± 0.20

PregS
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Figure 3.1. PregS (25 μM) robustly increases the frequency of AMPA-mEPSCs in
PCs from neonatal rats.
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Figure 3.2. The PregS (25 μM)-induced increase in AMPA-mEPSC frequency is
independent of NMDA, glycine, σ1, or α7nACh receptors.
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Figure 3.3. PregS (25 μM) increases AMPA-mEPSC frequency by elevating [Ca2+]i
possibly via modulation of TRP channels.
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Figure 3.4. PregS (25 μM) increases CF-eEPSC amplitude and decreases the PPR in
PCs from neonatal rats.
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Figure 3.5. PregS (25 μM) does not affect CF-eEPSC amplitude or the PPR in PCs
from juvenile rats.
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Figure 3.6. PregS (25μM) does not affect PF-eEPSC amplitude or the PPR in PCs
from juvenile rats.
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Figure 3.7. PregS (25μM) increases the frequency of GABAA-mPSCs in PCs from
neonatal rats
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4.1 Abstract
The functional implications of transient receptor potential melastatin 3 (TRPM3)
activation, the most recently described member of the melastatin subfamily of cation
permeable TRP channels, have begun to be elucidated in recent years. The discovery of
TRPM3 activation by the steroid pregnenolone sulfate (PregS) has shed new light on the
physiological role of TRPM3. For example, TRPM3 activation enhances insulin secretion
from β pancreatic cells, induces contraction of vascular smooth muscle cells, and is also
involved in the detection of noxious heat. Although TRPM3 expression has been detected
in several regions of the developing and mature brain, little is known about the roles of
TRPM3 in brain physiology. Here, we demonstrate the abundant expression of TRPM3
steroid-sensitive channels in the developing cerebellar cortex. We also show that
TRPM3-like channels are expressed at glutamatergic synapses in neonatal PCs. We
recently showed that PregS potentiates spontaneous glutamate release onto neonatal
Purkinje cells (PCs) during a period of active glutamatergic synapse formation; we now
show that this effect of PregS is mediated by TRPM3-like channels. Mefenamic acid, a
recently discovered TRPM3 antagonist, blocked the effect of PregS on glutamate release.
The PregS effect on glutamate release was mimicked by other TRPM3 agonists
(nifedipine and the epipregnanolone sulfate) but not by a TRMP3-inactive steroid
(progesterone). Our findings identify TRPM3 channels as novel modulators of
glutamatergic transmission in the developing brain.
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4.2 Introduction
The mammalian transient receptor potential melastatin (TRPM) channel
subfamily includes 8 members based on their homology to melastatin, a putative tumor
suppressor that may be involved in the pathophysiology of melanoma. The members of
the TRPM subfamily are characterized by sequence similarities along the 700 amino-acid
long N-terminus and transmembrane domains, whereas the C-terminal domains show
diverse structures (reviewed in (Venkatachalam and Montell, 2007, Wu et al., 2011).
TRPM proteins assemble into ion conducting channels that respond to a variety of stimuli
including temperature, osmolarity, various chemical signals, changes in membrane
voltage, oxidative stress and intracellular Ca2+ (Harteneck, 2005). While most of the
TRPM channels are activated in a unique manner, TRPM3 behaves as a polymodal
regulated ion channel (Harteneck and Schultz, 2007, Oberwinkler and Phillipp, 2007).
Beside the recently described activation by temperature, TRPM3 is activated by the
neuroactive steroids pregnenolone sulfate (PregS) and epipregnanolone sulfate, as well as
by the L-type voltage-gated Ca2+ channel antagonist, nifedipine, and hypotonicity
(Grimm et al., 2003, Lee et al., 2003, Grimm et al., 2005, Wagner et al., 2008, Majeed et
al., 2010, Vriens et al., 2011).

Electrophysiological experiments in heterologous

expression systems demonstrated that TRPM3 forms an ion channel permeable to Ca2+,
Na+, Mg2+, and Mn2+ (Grimm et al., 2005, Oberwinkler et al., 2005a). The polymodal
activation mode of TRPM3 corresponds to the diversity of cells expressing TRPM3;
these channels have been linked to vascular smooth muscle contraction, modulation of
glucose-induced insulin release from pancreatic islets, detection of noxious heat in dorsal
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root ganglia and in development of oligodendrocytes (Wagner et al., 2008, Hoffmann et
al., 2010, Naylor et al., 2010, Vriens et al., 2011).
Since the first functional description of TRPM3, northern blot analyses argue for
the expression of TRPM3 in the brain (Grimm et al., 2003, Lee et al., 2003, Oberwinkler
et al., 2005a). These studies revealed the presence of several distinct transcription
products in the mouse brain. The detection of sequence discrepancies due to alternative
splicing and exon usage suggests the expression of multiple TRPM3 mRNA transcripts
(Lee

et

al.,

2003,

Oberwinkler

et

al.,

2005).

In

situ

hybridization

and

immunohistochemistry approaches revealed expression of TRPM3 in the epithelial cells
of the choriod plexus, oligodendrocytes and neurons (Oberwinkler et al., 2005, Hoffmann
et al., 2010). The functional consequences of TRPM3 activation in the brain have just
begun to be elucidated and one physiological role for TRPM3 in the brain has been
recently suggested. At the onset of myelination and into adulthood, TRPM3 expression
was found in oligodendrocytes, where TRPM3 activation induced increases in
intracellular Ca2+. These findings suggest that TRPM3 channels are important players in
oligodendrocyte differentiation and CNS myelination (Hoffmann et al., 2010). In the
immature brain, the presence of TRPM3 was also detected (Hoffmann et al., 2010);
however, the physiological role of these channels in the developing brain has not been
explored. Studies from our laboratory suggest that the TRPM3 activator, PregS, is an
important regulator of the formation and refinement of glutamatergic synapses in the
developing brain (Mameli et al., 2005, Valenzuela et al., 2008). In the developing
cerebellum, PregS potently and reversibly enhances glutamate release onto Purkinje cells
(PCs) of neonatal rats, an effect that is independent of the known PregS-sensitive targets
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N-Methyl-D-aspartate (NMDA), glycine, α7 nicotinic acetylcholine, and σ1 receptors, as
well as voltage-gated Ca2+ channels (Zamudio-Bulcock and Valenzuela, 2011). PregS
increases glutamate release by enhancing Ca2+ entrance into presynaptic terminals via a
target that is sensitive to La3+, a blocker of TRP channels (Zamudio-Bulcock and
Valenzuela, 2011). Based on this finding, we hypothesized that TRPM3 channels are
expressed at developing glutamatergic synapses on PCs and that they mediate the PregSinduced enhancement in glutamatergic transmission. We tested this hypothesis using
immunohistochemistry and slice electrophysiology.

4.3 Materials and Methods
Unless specified, all chemicals were from Sigma (St. Louis, MO) or Tocris Bioscience
(Ellisville, MO). All experiments were approved by the University of New Mexico
Health Sciences Center Institutional Animal Care and Use Committee and conformed to
National Institutes of Health guidelines.

4.3.1 Immunohistochemistry
TRPM3

expression

in

the

cerebellar

cortex

was

studied

using

immunohistochemistry. For these experiments, parasagittal cerebellar cortex sections
were prepared from 5 postnatal day (P) 6-8 Sprague Dawley rats from three different
litters. Tissue preparation was performed as follows: brains were removed after deep
anesthesia with 250 mg/kg ketamine and immersion-fixed in 4% paraformaldehyde
overnight. Subsequently, brains were cryo-protected in 30% sucrose in phosphate
buffered saline (PBS) at 4°C until they sank to the bottom. Brains were then imbedded in
O.C.T compound (Tissue Tek, the Netherlands) and flash-frozen by submersion in
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isopentane cooled in a dry ice/methanol bath. Brains were then cryo-sectioned in the
sagittal plane and placed on superfrost plus micro slides (VWR international, West
Chester, PA), stored at -20oC for a period no longer than two weeks. Sections were
washed 3 times in PBS and permeabilized with 0.5% Triton X-100. Simultaneously,
nonspecific binding was blocked with 10% normal donkey serum, 10% normal goat
serum, and 10% bovine serum albumin. Primary antibodies (polyclonal rabbit antiTRPM3; polyclonal guinea pig anti-VGlut2, AB5907 Millipore, Billerica, MA; and
monoclonal mouse anti-calbindin, sc-70478, Santa Cruz Biotechnology, Inc, Santa Cruz,
CA), were incubated overnight at 4oC. The TRPM3 antibody was raised in rabbits and
affinity purified as previously described (Hoffmann et al., 2010), using the following
synthetic

peptide

NH2-CDMPYMSQAQEIHLQEKEAEEPEKPTKE-CONH2

corresponding to positions 795 to 821 of TRPM3 splice variants A and B. All secondary
antibodies were purchased from Millipore. Secondary antibodies (goat anti-rabbit alexa
fluor 555 for TRPM3 detection, donkey anti-guinea pig CY5 conjugate for VGlut2
detection and donkey anti-mouse alexa 488 for calbindin detection) were incubated for 1
h at room temperature. Sections were rinsed and mounted with Vectashield (Vector
Laboratories, Burlingame, CA) and examined with a Zeiss LSM510 confocal microscope
(Carl Zeiss, Germany). Z-stack images were taken using a 40x immersion objective and
an optical section thickness of 1 µm, which was the optimal pinhole diameter for best
resolution. Detector gain and laser percent output parameters were optimized for each
channel in one section and maintained throughout all the studies. Two z-stack image files
from different cerebellar cortical regions were taken per each animal.
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Co-localization was determined using Slidebook 5 image analysis software
(Intelligent Imaging Innovations, Inc., Denver, CO). After background subtraction for
each individual channel, one mask per channel was created. Subsequently, the area over
the PC layer region was selected and extrapolated to each image in the z-stack. Then, a
colocalization mask across two channels within that area was created. Colocalization
masks were created using the math function “AND”, which recognizes the voxels that are
positive for both proteins. Percent colocalization was calculated using the total number of
voxels in an individual channel mask compared to the number of colocalized voxels in
the respective colocalization mask. The triple colocalization analysis was done by
creating a new colocalization mask using the colocalization mask for two given channels
and the mask of the individual channel that was not considered in the first colocalization
mask (Vo et al., 2004).

4.3.2 Slice electrophysiology
Cerebellar vermis parasagittal slices (250 μm-thick) were prepared from neonatal
(P4–P10) Sprague–Dawley rats.

Alpha-amino-3-hydroxy-5-methyl-4- isoxazole-

propionic acid (AMPA) channel-mediated miniature excitatory postsynaptic currents
(AMPA-mEPSCs) were recorded from PCs. The artificial cerebrospinal fluid (ACSF)
was equilibrated with 95% O2/5% CO2 and contained the following (in mM): 126 NaCl,
2 KCl, 1.25 NaH2PO4, 1 MgSO4, 26 NaHCO3, 2 CaCl2, 10 glucose, 10 μM 6-imino-3-(4methoxyphenyl)-1(6H)-pyridazinebutanoic acid (SR 95531), and 0.5 μM tetrodotoxin
(TTX; Calbiochem, La Jolla, CA). The internal solution contained (in mM): 150 CsCl,
1.5 MgCl2, 10 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (HEPES), 0.1 1,2bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) (Calbiochem, La Jolla,
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CA), 2 Na2-ATP, 0.4 Na-GTP, at pH 7.3.

Using these recording conditions, we

previously demonstrated that the mEPSC are blocked by 1-(4-aminophenyl)-3methylcarbamyl-4-methyl-3,4-dihydro-7,8-methylenedioxy-5H-2,3-benzodiazepine
(GYKI 53655; 50 µM), confirming that these events are AMPA receptor mediated
(Zamudio-Bulcock and Valenzuela, 2011). If the access resistance changed >30%, the
recording was discarded. The membrane potential was held at -70 mV.
Data were acquired with pClamp 10 (Molecular Devices, Sunnyvale, CA) at a
filtering frequency of 2 kHz and an acquisition rate of 10 kHz. Miniature events were
analyzed using Mini Analysis (Synaptosoft, Decatur, GA). In all cases, changes in
mEPSC frequency were quantified by measuring changes in inter-event interval.
Individual recordings were analyzed using the Kolmogorov–Smirnov (K–S) test using a
conservative value for significance of p <0.01. Statistical analyses of pooled data were
performed with GraphPad Prizm 4 (GraphPad Software, San Diego, CA). Data were
initially analyzed with the D’Agostino and Pearson omnibus normality tests. If data
followed a normal distribution, these were analyzed using parametric tests. If this was not
the case, then non-parametric tests were used. The level of significance was p <0.05. Data
were normalized to baseline and expressed as percent of baseline ± standard error of the
mean.
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4.4 Results
4.4.1 TRPM3 expression in the neonatal cerebellar cortex
We performed immunohistochemistry experiments to assess the expression of
TRPM3 in the neonatal cerebellar cortex in parasagittal sections from P6-8 rats. During
the neonatal period, the cerebellar cortex is a four layered structure consisting of the
external granule cell, the nascent molecular, the PC and the internal granule cell layers
(Fig 4.1A). Glutamatergic axons form temporary somatic synaptic protrusions on PC
bodies, which are arranged in a pseudomonolayer (Kurihara et al., 1997, Eilers et al.,
2001, Kawa, 2003). During the first 14 postnatal days, all glutamatergic terminals onto
PCs express the vesicular glutamate transporter VGlut2. Subsequently, VGlut2 is
expressed selectively in climbing fiber (CF) terminals and VGlut1 becomes the main
vesicular glutamate transporter in parallel fiber (PF) terminals (Miyazaki et al., 2003).
Therefore, we used VGlut2 as a marker for glutamatergic terminals in the neonatal
cerebellar cortex. To detect PCs, we used the Ca2+-binding protein calbindin, which is
highly expressed in PCs. We found a strong TRPM3 expression in PCs (Fig. 4.1A). Other
cells within the PC layer were labeled by the anti-TRPM3 antibody; based on their
localization, these cells likely correspond to developing Bergman glia, which enwrap CF
-to-PC synapses during postnatal development (Douyard et al., 2007). Interestingly,
TRPM3 was also found in the inner granule cell layer, the nascent molecular layer, and
the external granule cell layer (Fig. 4.1A). Preincubation of the anti-TRPM3 antisera with
the synthetic peptide used for immunization, completely blunted the staining reaction,
demonstrating the specificity of the immunohistochemical assay (Fig. 4.1B).
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4.4.2 TRPM3 is expressed at glutamatergic synapses in neonatal PCs
TRPM3 expression in the PC layer and its localization with glutamatergic
synapses in the PC layer at P6-8 was further analyzed by quantifying signals from
double- and triple-stained sections. We found TRPM3 abundantly expressed in PC cell
bodies; the quantification revealed that 37.32 ± 11.1 % (Fig. 4.2A; n = 5) of calbindin
colocalized with TRPM3 and 22.64 ± 3.56 % (not shown; n = 5) of TRPM3 staining
overlapped with calbindin staining. In addition, 43.37 ± 4.84 % of glutamatergic
terminals on PCs, visualized by VGlut2 and calbindin staining, were also positive for
TRPM3 (Fig. 4.2B, n = 5). Consistent with the presence of immature CF terminals not
associated with PCs at this age (Hashimoto et al., 2009), not all VGlut2 staining
colocalized with calbindin (32.06 ± 3.13 %, not shown; n = 5).

4.4.3 Characterization of increases in glutamate release induced by TRPM3-like
channels.
Our previous finding that PregS increases glutamate release at PCs, taken together
present results indicating that TRPM3 channels are expressed at glutamatergic synapses
in these cells, prompted us to assess the role of these channels in the mechanism of action
of PregS. To this end, we used recently characterized TRMP3 pharmacological tools.
Within the group of fenamates, a class of small compounds derived from N-phenylsubstituted anthranilic acid, mefenamic acid has been described to selectively block
TRPM3 with a half-maximal inhibitory concentration of 6.6 ± 1.8 µM (IC50 of > 300 µM
on other TRP channels) (Klose et al., 2011). Therefore, we tested whether the PregSinduced increase of quantal glutamate release was affected by this potent TRPM3 channel
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blocker. To measure quantal glutamate release, we recorded AMPA-mEPSC from PCs
using whole-cell patch-clamp techniques.

Using this approach, we previously

demonstrated that PregS reversibly increases AMPA-mEPSC frequency but not
amplitude, indicating that this neuroactive steroid acts by increases glutamate release
rather than via modulation of postsynaptic AMPA receptors (Zamudio-Bulcock and
Valenzuela, 2011). Mefenamic acid (25 μM) significantly attenuated the PregS-induced
increase in AMPA-mEPSC frequency. The K-S test showed that, in the presence of
mefenamic acid, PregS did not significantly change the inter-event interval in 2 out of 5
cells, significantly increased it in 1 cell and significantly decreased it in 2 cells. In
controls, PregS strongly increased AMPA-mEPSC frequency (4,716 ± 1,755 % of
baseline, n = 5) (Fig.4.3A, B, E and F). However, in the presence of mefenamic acid, this
PregS dependent increase was significantly reduced (138.7 ± 39.58 % of baseline, n = 5)
(Fig. 4.3C, D, E and F).
Epipregnanolone sulfate, a pregnanolone isomer derived from progesterone, has
been shown to activate recombinant TRPM3 channels expressed in HEK cells (Majeed et
al., 2010). Therefore, we tested whether bath application of epipregnanolone sulfate
affected glutamatergic transmission onto neonatal cerebellar PCs. Bath application of
epipregnanolone sulfate (25 µM) significantly increased AMPA-mEPSC frequency
(454.3 ± 95.3 % of baseline, n = 11) (Fig. 4.4A and C). The K-S test showed that 9 out of
11 cells had a significant decrease in the inter-event interval. The amplitude of these
events was not significantly affected by epipregnanolone sulfate (106.2 ± 9.95 % of
baseline). The K-S test showed that in 8 out of 11 cells, epipregnanolone sulfate did not
significantly affect AMPA-mEPSC amplitude; in 3 out of 11 cells, it induced a
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significant decrease in the amplitude of these events. We have previously reported that
the TRP channel blocker, La3+, blocks the PregS-induced increase in AMPA-mEPSC
frequency (Zamudio-Bulcock and Valenzuela, 2011). In the presence of La3+ (100 µM),
epipregnanolone sulfate did not significantly increase AMPA-mEPSC frequency (114.9 ±
16.22 % of baseline, n = 8) (Fig. 4.4C, D, E and F). The K-S test showed that in the
presence of La3+, epipregnanolone sulfate did not significantly affect the inter-event
interval in 5 out of 8 cells and that there was a significant decrease in 2 out 8 cells, and a
significant increase in 1 cell.
As a control, we tested progesterone, a steroid that has been shown to lack at
stimulating actions on TRPM3 (Wagner et al., 2008, Majeed et al., 2010). The
application of progesterone (25 µM) affected neither the frequency (107.1 ± 15.57 % of
baseline, n = 6) nor the amplitude (108 ± 10.15 % of baseline) of AMPA-mEPSCs (Fig.
4.5). In 5 out of 6 cells, the K-S test showed no significant change in the inter-event
interval of these events. The K-S test showed no significant change in AMPA-mEPSC
amplitude in 4 out of 6 cells; there was a significant increase in 1 cell and a significant
decrease in 1 cell.
The increase in AMPA-mEPSC frequency induced by steroid sulfates and the
blockade of this effect by both mefenamic acid and La3+ provide strong evidence for the
participation of TRPM3-like channels in this process. To exclude effects based on the
steroid structure of the activating compounds, we chose nifedipine, a non-steroideal Ltype Ca2+ channel blocker with TRPM3-stimulating properties (Wagner et al., 2008).
Bath application of nifedipine (20 µM) significantly increased AMPA-mEPSC frequency
(2,680 ± % of baseline, n = 8) (Fig. 4.6A,B,E and F). The K-S test showed that in 8 out of
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8 cells there was a significant decrease in the inter-event interval. The average amplitude
of AMPA-mEPSCs was not significantly changed by nifedipine (90.92 ± 2.25% of
baseline) (Fig. 4.6A and B). The K-S test showed that, in 5 out of 8 cells, nifedipine did
not change the amplitude of these events. In the other 3 cells, nifedipine significantly
decreased the amplitude of these events. La3+ (100 µM) significantly reduced the
nifedipine-induced increase of AMPA-mEPSC frequency (169.1 ± 44.67 % of baseline, n
= 9) (Fig. 4.6C and D). In the presence of La3+, the K-S test showed that nifedipine did
not change the inter-event interval of these events in 5 out of 9 cells, and that it
significantly decreased it in 3 out of 9 cells and increased it in 1 cell.

72

4.5 Discussion
This study provides evidence supporting the hypothesis that TRPM3 channels
mediate the effect of PregS on glutamate release in the neonatal cerebellar cortex and
constitutes the first demonstration of a physiological effect of TRPM3 channels in
neurotransmission. The findings can be summarized as follows. Immunohistochemistry
experiments indicate that TRPM3 splice variants A and/or B are abundantly expressed in
the developing cerebellar cortex and that these colocalize with glutamatergic synapses in
PCs. Furthermore, the previously reported effect of PregS on the frequency of AMPAmEPSCs is inhibited by the TRPM3 blocker, mefenamic acid. In addition, the TRPM3
agonists, epipregnanolone sulfate and nifedipine, mimicked the PregS-induced increase
of AMPA-mEPSC frequency; however, the TRPM3 inactive agent progesterone was not
able to mimic the PregS effect.

4.5.1 TRPM3 channels are expressed in the developing cerebellar cortex
The expression of TRPM3 channels in the neonatal cerebellar cortex was found to
be abundant and present in all 4 layers of the developing cerebellar cortex. This
expression profile suggests that these channels may play a role in the maturation of
cerebellar cortex circuitry. During the neonatal period there are ongoing cell maturation
and migration processes that depend heavily on Ca2+ signaling and, therefore, might be
influenced by TRPM3 channel activation. Certainly, future studies should focus on
investigating the role of these channels on the overall development of the cerebellar
cortex.
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Importantly, our results suggest that a considerable number of VGlut2-containing
glutamatergic synapses in PCs contain TRPM3 channels, although electron microscopic
studies are needed to elucidate the precise synaptic compartment containing these
channels. TRPM3 and calbindin showed colocalization, but most of the TRPM3 staining
in the PC layer was not localized on PCs. Collectively, these results indicate that in the
PC layer, TRPM3 is expressed in three locations. First, TRPM3 is localized in VGlut2
positive glutamatergic synapses onto PCs, which, at least in part, correspond to CF-to-PC
synapses, as suggested by our finding that PregS alters paired-pulse plasticity of CFevoked EPSCs (Zamudio-Bulcock and Valenzuela, 2011). Second, TRPM3 is present in
PC somata in locations other than glutamatergic synapses, perhaps in developing
GABAergic pinceaux synapses and/or axonal collaterals from neighboring PCs (Watt et
al., 2009); supporting this possibility are previous findings that PregS, although less
strongly, also increases GABAergic transmission onto neonatal PCs (Zamudio-Bulcock
and Valenzuela, 2011). Third, TRPM3 is expressed in other cell types present in the
developing PC layer, with the most likely candidates being Bergman glia and migrating
granule cells. In the neonatal cerebellar cortex, Bergmann glial fibers associate with
granule cells migrating from the external granule cell layer to their final destination in the
internal granule cell layer. Therefore, it will be important to assess whether these
channels are located on Bergmann glia and play a role in this process (Yamada et al.,
2000).
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4.5.2 Steroid-sensitive TRPM3 channels increase glutamate release
We have previously shown that the effect of PregS on glutamatergic transmission
in the neonatal cerebellar cortex is blocked by the non-selective TRP channel blocker,
La3+. Mefenamic acid, a clinically used non-steroidal anti-inflammatory agent, was
recently shown to be a selective and potent TRPM3 blocker (Klose et al., 2011). This
finding enabled us to more selectively test the involvement of TRPM3 channels in the
mechanism of action of PregS. Mefenamic acid blocking of the PregS-induced increase
of AMPA-mEPSC frequency provided the first line of evidence of the involvement of
this channel in the PregS effect.
PregS and epipregnanolone sulfate are structurally related compounds. Not
surprisingly, similar to PregS, epipregnanolone sulfate has been shown to inhibit GABAA
receptors (Park-Chung et al., 1999). PregS is a positive modulator of NMDA receptors
whereas epipregnanolone sulfate inhibits these receptors by acting at a distinct site from
that of PregS (Park-Chung et al., 1997). In the case of TRPM3 stimulation, both PregS
and epipregnanolone sulfate act at the same site; however, these agents stimulate TRPM3
with a different efficacy. PregS-mediated stimulation of TRPM3 channels requires the
sulfate group positioned at ring A and the cis (β) configuration of the side group, both of
which epipregnanolone sulfate possess. In fact, the structure of epipregnanolone sulfate
only differs from that of PregS in that it lacks the double bond in ring B and this
structural difference renders epipregnanolone sulfate less effective in stimulating TRPM3
channels. In HEK cells expressing TRPM3 channels, epipregnanolone sulfate was shown
to be less potent than PregS at increasing intracellular Ca2+ (Majeed et al., 2010).
Consistent with these findings, we observed that epipregnanolone sulfate significantly
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increased the frequency of AMPA-mEPSCs in neonatal PCs (Fig. 4.1), but this effect was
of lower magnitude than that induced by the same concentration of PregS (Fig. 4.4).
Importantly, similar to the PregS-induced increase in AMPA-mEPSC frequency, this
effect was blocked by the TRP channel blocker, La3+ (Zamudio-Bulcock and Valenzuela,
2011).
Progesterone is a major neurosteroid shown to be inactive at TRPM3 channels
(Wagner et al., 2008, Majeed et al., 2010). In-vitro and in-vivo studies have shown that
progesterone promotes dendritic growth and spine formation in PCs via modulation of its
nuclear receptor, although a role of progesterone membrane receptors in this trophic
effect has not been ruled out (reviewed in (Tsutsui et al., 2003). Progesterone is known to
modulate the release of norepinephrine, serotonin, dopamine, and glutamate. In the
prefrontal cortex, progesterone inhibits the dopamine-evoked release of glutamate while
it does not affect spontaneous release (reviewed in (Zheng, 2009). Here, we report that
progesterone neither affected the frequency nor the amplitude of AMPA-mEPSCs. These
results are consistent with the lack of activity of this neurosteroid on TRPM3.
Additionally, these results argue against acute modulation of spontaneous glutamatergic
transmission as a mechanism responsible for some of the trophic effects of progesterone
on neonatal PCs.

4.5.3 Nifedipine mimics the effect of PregS
Nifedipine is an L-type calcium channel blocker clinically used for the treatment
of conditions such as cardiac arrhythmias, angina, hypertension, and preterm labor
(Hirasawa and Pittman, 2003, Conde-Agudelo et al., 2011). Recently, nifedipine was
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shown to paradoxically activate TRPM3 channels in recombinant experiments and in
pancreatic islets cells with potency similar to that of PregS (Wagner et al., 2008). It is
noteworthy that activation of voltage-gated Ca2+ channels is not involved in the effect of
PregS on neonatal PCs, as bath application of Cd2+ does not prevent the PregS-induced
increase in AMPA-mEPSC frequency (Zamudio-Bulcock and Valenzuela, 2011). In this
study, we show that nifedipine mimics the previously reported PregS-induced increase in
glutamate release onto neonatal PCs and that, like the effect of PregS, this effect is
sensitive to TRP channel blockade by La3+. Ca2+ channel blockers, including nifedipine,
are used in obstetrics and gynecology for the management of hypertensive disorders of
pregnancy and preterm labor. The teratogenicity of these agents has been reported in
animals; however, human data are inconclusive (Tranquilli and Giannubilo, 2009).
Nevertheless, a recent systematic review linked the use of nifedipine and other Ca2+
channel blockers with significant higher risks for a wide range of feto-maternal adverse
events, including cardiac, respiratory, and renal alterations (Khan et al., 2011). Given that
nifedipine can readily cross the blood brain barrier (Janicki et al., 1988), and that human
TRPM3 channels are also strongly modulated by PregS and other TRPM3 channel
activators (Majeed et al., 2010), our results suggest that using nifedipine during the thirdtrimester of pregnancy should be avoided, as it may cause alterations in cerebellar
neuronal circuit formation.

Importantly, this effect may not be limited to cerebellar

neurons, as another study showed that nifedipine increases glutamate release in
magnocellular neurons of the supraoptic nucleus via a Ca2+ channel-independent
mechanism (Hirasawa and Pittman, 2003).
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In conclusion, the present study provides evidence indicating that TRPM3
channels are novel modulators of glutamatergic transmission. A mature PC receives
glutamatergic input from numerous granule cell projections, the PFs, and from a single
axonal projection of an inferior olivary neuron, the CF. The one to one CF-to-PC
association is preceded during development by multinumerary CF-to-PC synapses and it
is achieved at the end of the second postnatal week in rodents (approximately equivalent
to end of the third trimester of human pregnancy) via synaptic competition among CFs
and between CF and PFs. In addition, CF synapse formation starts during embryonic
development, while PF-to-PC synapse formation starts at the end of the first postnatal
week (Bosman and Konnerth, 2009, Cesa and Strata, 2009). During the developmental
period at which the TRPM3-mediated enhancement of glutamate release occurs, the
multinumerary CF-to-PC synapses are functionally differentiated and the process of early
synapse elimination starts (Kano and Hashimoto, 2009). While the mechanisms
controlling the late stages of CF synapse elimination are rather well understood (Bosman
and Konnerth, 2009, Kano and Hashimoto, 2009), the early stages of CF synapse
elimination have not been fully characterized. CF plasticity mechanisms may play a
central role in CF functional differentiation and elimination. It has been shown that, in
response to the same stimuli, strong CF inputs undergo long-term potentiation while
weak ones undergo long-term depression (Bosman et al., 2008, Ohtsuki and Hirano,
2008, Valenzuela et al., 2010). The mechanisms underlying the differential synaptic
properties among CFs are not well understood. We previously showed that the PregSinduced enhancement of glutamate release occurs at developing CF-to-PC synapses
(Zamudio-Bulcock and Valenzuela, 2011). Therefore, the interesting possibility that
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TRPM3 channel activation by PregS-like neurosteroids released from Purkinje neurons is
involved in the differential strengthening of CF inputs needs to be further assessed.
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FIGURE LEGENDS
Figure 4.1. Pseudocolored confocal images of TRPM3 expression profile in the
neonatal cerebellar cortex. (A) TRPM3 (blue), calbindin (red) and VGlut2 (green)
expression in a 2 μm-thick sagittal cerebellar confocal section at P8. Channels are shown
separately and a merged image is shown in the bottom right division. Similar results were
obtained in sections from 4 additional rats. (B) Competition with the immunizing peptide
eliminates TRPM3 protein staining. Similar results were obtained in sections from
another rat.

External granule cell layer (EGC; nascent molecular layer located

immediately above PC layer is not shown for clarity), Purkinje cell layer (PC), internal
granule cell layer (IGC). Scale bars: 50 μm.

Figure 4.2. Confocal images and colocalization masks for TRPM3, VGlut2 and
calbindin in the PC layer. (A) Top, merge of calbindin (red) and TRPM3 (blue).
Bottom, colocalization of calbindin and TRPM3 is illustrated by masking of regions with
no overlap between these proteins. Confocal images correspond to a 1 μm thick sagittal
cerebellar confocal section at P8. (B) Top, merged image of TRPM3 (blue), calbindin
(red) and VGlut2 (green). Bottom, colocalization of calbindin, TRPM3, and VGlut2 is
illustrated by masking of regions with no overlap between these proteins. Scale bars: 50
μm. See text for quantification of results from 5 separate experiments.
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Figure 4.3. Mefenamic acid inhibits the PregS-induced increase of AMPA-mEPSC
frequency. (A) Sample traces of AMPA-mEPSC recordings at P7 in a control PC
(calibration: 20 pA, 0.5 s) and corresponding average mEPSC traces (calibration: 8 pA, 3
ms). (B) Corresponding cumulative probability plots; PregS significantly decreased the
inter-event interval (p < 0.01 by K–S test) but not the amplitude. (C) Sample traces of
AMPA-mEPSC recordings in the presence of mefenamic acid (Mef) at P6 (calibration:
20 pA, 0.5 s) and corresponding average mEPSC traces (calibration: 8 pA, 3 ms). (D)
Corresponding cumulative probability plots. (E) Time courses of AMPA-mEPSC
frequency corresponding to the control and mefenamic acid recordings shown in A and
C. (F) Summary of the effect of PregS on AMPA-mEPSC frequency. In the presence of
mefenamic acid the effect of PregS was significantly reduced (Mann-Whitney test, ** p
<0.05; n = 5).

Figure 4.4. Epipregnanolone sulfate increases AMPA-mEPSC frequency. (A)
Sample traces of AMPA-mEPSC recordings at P6 in a control PC (calibration: 20 pA, 0.5
s) and corresponding average traces (calibration: 6 pA, 8 ms). (B) Corresponding
cumulative probability plots; epipregnanolone sulfate significantly decreased the interevent interval (p < 0.01 by K–S test) but not the amplitude of these events. (C) Sample
traces of AMPA-mEPSC recordings in a La3+ treated cell at P7 (calibration: 20 pA, 0.5 s)
and corresponding average traces (calibration: 8 pA, 12 ms). (D) Corresponding
cumulative probability plots; in the presence of La3+ neither the inter-event-interval nor
the amplitude of these events was affected by epipregnanolone sulfate. (E) Time courses
of AMPA-mEPSC frequency corresponding to the control and the La3+ recordings shown
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in A and C. (F) Summary of the effect of epipregnanolone sulfate (EpipregnanS) on
AMPA-mEPSC frequency. In the presence of La3+ the effect of epipregnanolone sulfate
was significantly reduced (Mann-Whitney test, ** p <0.05; n = 8).

Figure 4.5. Progesterone changes neither the frequency nor the amplitude of
AMPA-mEPSCs. (A) Sample traces of AMPA-mEPSC recordings at P9; calibration: 20
pA, 0.2 sec. Average traces calibration: 4 pA, 3 ms. (B) Corresponding cumulative
probability plots for amplitude (left panel) and inter-event interval (right panel). (C) Time
course of AMPA-mEPSC frequency for the recordings shown in A. (D) Summary of the
effect of progesterone on AMPA-mEPSC frequency (n = 6).

Figure 4.6. Nifedipine increases AMPA-mEPSC frequency. (A) Sample traces of
AMPA-mEPSC recordings at P6 in a control PC (calibration: 50 pA, 0.5 s) and
corresponding average traces (calibration: 4 pA, 10 ms). (B) Corresponding cumulative
probability plots; nifedipine significantly decreased the inter-event interval (p < 0.01 by
K–S test) without affecting the amplitude. (C) Sample traces of AMPA-mEPSC
recordings in La3+ at P8 (calibration: 50 pA, 0.2 s) and corresponding average traces
(calibration: 4 pA, 4 ms). (D) Corresponding cumulative probability plots illustrating the
lack of a significant effect of nifedipine in presence of La3+. (E) Time courses of AMPAmEPSC frequency corresponding to the control and the La3+ recordings shown in A and
C. (F) Summary of the effect of nifedipine on AMPA-mEPSC frequency. In the presence
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of La3+, the effect of nifedipine was significantly reduced (Mann-Whitney test, *** p
<0.0001; n = 9).
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Figure 4.1. Pseudocolored confocal images of TRPM3 expression profile in the
neonatal cerebellar cortex.
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Figure 4.2. Confocal images and colocalization masks for TRPM3, VGlut2 and
calbindin in the PC layer.
A

B

Calbindin + TRPM3
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TRPM3 + VGlut2 + Calbindin

Figure 4.3. Mefenamic acid inhibits the PregS-induced increase of AMPA-mEPSC
frequency.
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Figure 4.4. Epipregnanolone sulfate increases AMPA-mEPSC frequency.
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Figure 4.5. Progesterone changes neither the frequency nor the amplitude of
AMPA-mEPSCs.
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5. Preventing the degradation of sulfated steroids enhances
glutamatergic transmission at developing cerebellar Purkinje cells in
hindbrain organotypic cultures

5.1 Abstract
Immature and mature cerebellar Purkinje cells (PCs) have been shown to
synthesize the steroid precursor, pregnenolone. Pregnenolone metabolites such as
progesterone and estradiol have been shown to modulate the development of PC
morphology. However, the role of sulfated steroids on the development of PCs is
unknown. Recently, we have reported that exogenous bath application pregnenolone
sulfate (PregS) potently enhances glutamate release onto neonatal PCs in acute slice
preparations. Here, we show that increasing the levels of endogenous sulfated
neurosteroids during development via sulfatase inhibition, enhances glutamatergic
transmission at PCs in organotypic hindbrain cultures. In addition, we show that
prolonged exposure to DU-14 has deleterious effect on PC viability. Our results indicate
that endogenous PregS-like neurosteroids can modulate glutamatergic transmission at
developing PCs.

5.2 Introduction
We have demonstrated that exogenous application of the sulfated neurosteroid,
pregnenolone sulfate (PregS) potently and reversibly enhances glutamate release at
developing Purkinje cells (PCs) (Zamudio-Bulcock and Valenzuela, 2011), via
modulation of transient receptor potential M3 (TRPM3 channels) during an active period
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of synapse formation. However, whether endogenous PregS-like neurosteroids regulate
the development of glutamatergic synapses at PCs remains unknown. We showed that the
effect of PregS on glutamatergic transmission was present at neonatal (P4-10), but not at
juvenile (P15 to P21) climbing fiber (CF)-to-PC synapses. In juvenile parallel fiber (PF)to-PC synapses, PregS did not affect glutamate release (Zamudio-Bulcock and
Valenzuela, 2011). While CFs contact PCs at about embryonic day (E)19 (reviewed in
(Bosman and Konnerth, 2009)), PF-to-PC synapse formation is believed to start at the
end of the first postnatal week. Additionally, the migration of granule cells, which give
rise to PFs, is not complete until the end of the third postnatal week (Jiang et al., 2008),
indicating the ongoing presence of newly formed PF-to-PC synapses during the second
and third postnatal weeks. This suggests that if PregS modulated glutamatergic
transmission at developing PF-to-PC synapses, this effect could be detected in juvenile
PCs. Nonetheless, it remains uncertain if before P15 newly formed PF-to-PC synapses
are sensitive to PregS. Thus, it is of interest to study the physiological role of endogenous
PregS at both PF and CF-to-PC synapses. While PF inputs arise from the axonal
terminals of granule cells located within the cerebellar cortex, CFs arise from the axonal
projections of cells in the inferior olive, which is located in the medulla oblongata.
Therefore, to study the potential effect of PregS at both types of glutamatergic synapses,
we cultured hindbrain explants from rat embryos, which contain the cerebellar anlage as
well as the inferior olive. In this organotypic hindbrain culture system, PCs have been
shown to be innervated by both PF and CF terminals ((Chedotal et al., 1997, Letellier et
al., 2009), also see Appendixes 14 and 15). We used electrophysiological and
immunohistochemical techniques to test the effect of increasing the levels of endogenous
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sulfated neurosteroids on glutamatergic transmission at PCs in organotypic hindbrain
cultures.

5.3 Methods
All experiments were approved by the University of New Mexico Health Sciences
center institutional animal care and use Committee and conformed to National Institutes
of Health guidelines. Unless specified, all chemicals were from Sigma (St. Louis, MO),
Tocris Bioscience (Ellisville, MO), or Invitrogen (Madison, WI).

5.3.1 Organotypic cultures
Sprague-Dawley pregnant rats were anesthetized with Isofluorane and rat
embryos were quickly removed at embryonic day (E) 15-16. As previously described
(Chedotal et al., 1997, Letellier et al., 2009), embryos were placed in ice cold Gey's
balanced salt solution supplemented with glucose (6.5mg/ml), penicillin (100 U/ml),
streptomycin (100 µg/ml), and fungizone (1:1000) and HEPES (25 mM) and brains were
dissected out. The region between the tecto-cerebellar and medullo-spinal junctions,
which includes the cerebellar anlage and the inferior olive, was isolated. The rostrally
fused cerebellar plates were separated and the explants were positioned with their ventral
side down in contact with the membrane insert (pore size 0.4 µm) (Millipore, Billerica,
MA) (Fig. 5.1). The explants were kept in an atmosphere of humidified 5% CO2 at 37oC
for three weeks in a culture media containing 50% Earle's basal medium, 25% Hank's
balanced salt solution, 25% heat-inactivated horse serum, 1 mM L-glutamine, 5 mg/ml
glucose, penicillin (100 U/ml), streptomycin (100 µg/ml), and fungizone (1:2000).
Culture media was replaced every 2 days. From day in-vitro (DIV) 14 to 21, (DIV 0 was
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the plating day), explants were either exposed to 5 µM DU-14 (generously provided by
P.-K. Li, College of Pharmacy, Ohio State University HSC), vehicle, dimethyl sulfoxide
(0.025%), or were left untreated.

5.3.2 Electrophysiology
Whole-cell patch-clamp recordings were performed on PCs at DIV20-21 as
previously described for acute cerebellar slices (Zamudio-Bulcock and Valenzuela 2011).
The explants were placed in the recording chamber with their ventral side up and were
allowed to stabilize in the artificial cerebrospinal fluid (ACSF) at 34oC, for at least half
an hour before recordings were performed. PCs were recognized based on morphology
and location. An internal solution containing (in mM): 150 CsCl, 1.5 MgCl2, 10 HEPES,
0.1 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) (Calbiochem,
La Jolla, CA), 2 Na2-ATP, 0.4 Na-GTP, 5mM N-(2,6-Dimethylphenylcarbamoylmethyl)
triethylammonium bromide (QX-314) at pH 7.3 was used. The ACSF was equilibrated
with 95% O2/5% CO2 and contained the following (in mM): 126 NaCl, 2 KCl, 1.25
NaH2PO4, 1 MgSO4, 26 NaHCO3, 2 CaCl2, 10 glucose, 10 μM 6-imino-3-(4methoxyphenyl)-1(6H)-pyridazinebutanoic acid (SR 95531). Miniature excitatory
postsynaptic currents (mEPSCs) were recorded in the presence of 0.5 μM tetrodotoxin
(TTX; Calbiochem, La Jolla, CA). If the access resistance changed >30%, the recording
was discarded. The membrane potential was held at -70 mV.
Data were acquired with pClamp 10 (Molecular Devices, Sunnyvale, CA) at a
filtering frequency of 2 kHz and an acquisition rate of 10 kHz. Miniature events were
analyzed using Mini Analysis (Synaptosoft, Decatur, GA). Statistical analyses of pooled
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data were performed with GraphPad Prizm 4 (GraphPad Software, San Diego, CA). Data
shown as mean ± standard error of the mean.

5.3.3 Immunohistochemistry
Free-floating explants were immersion-fixed in 4% paraformaldehyde overnight. Then,
explants were washed 3 times in phosphate buffered saline (PBS) and permeabilized with
0.5% Triton X-100. Simultaneously, nonspecific binding was blocked with 10% normal
donkey serum, 10% normal goat serum and 10% bovine serum albumin. Primary
antibodies (polyclonal guinea pig anti-VGlut2; 1:500, AB5907 Millipore, Billerica, MA
and monoclonal mouse anti-calbindin 1:50, sc-70478, Santa Cruz Biotechnology, Inc,
Santa Cruz, CA), were incubated at 4oC for 24h. Secondary antibodies (donkey antimouse alexa 555, for calbindin detection, and goat anti-guinea pig alexa 488 for VGlut2
detection) , were incubated overnight at 4oC. Explants were then rinsed, placed on micro
glass superfrost slides (VWR international, West Chester, PA)

and mounted with

Vectashield mounting medium (Vector Laboratories, Burlingame, CA). Immunostainning
was examined with a Zeiss LSM510 confocal microscope (Carl Zeiss, Germany). The
intensity of calbindin stainning was quantified using the LSM510 Image Examiner
software (Carl Zeiss, Germany).

5.4 Results
5.4.1 Prolonged exposure to DU-14 reduces PC viability
To investigate whether glutamatergic transmission was affected by increasing the
levels of endogenous PregS-like neurosteroids, the explants were treated with the
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sulfatase inhibitor DU-14 (5 µM). Initially, hindbrain explants were exposed to DU-14 (5
µM) from DIV 12 to 20-28, chronologically equivalent to P7 to 23.

When

electrophysiological experiments were attempted in these explants at DIV20-28, we
noticed that in the DU-14 treated group the number of viable PCs was dramatically
decreased and electrophysiological recordings from these cells were not feasible.
Therefore, we examined the morphology of PCs using immunohistochemistry. Calbindin
immunostainning showed that, in DU-14 treated explants, the morphology of PCs was
visibly deteriorated at DIV 24 (Fig. 5.2A). Quantification of the intensity of calbindin
immunostainning in randomly selected regions of the cerebellar plates showed a
significant reduction in calbindin expression in DU-14 treated explants when compared
to dimethyl sulfoxide controls (Fig. 5.2B).

5.4.2 Shorter DU-14 exposure increases the frequency but not the amplitude of activitydependent and independent glutamatergic transmission at PCs
For these experiments, the cultures were divided into three groups, namely:
untreated controls, vehicle (dimethyl sulfoxide, 0.025 %) treated, and DU-14 (5 µM)
treated. The treatment time was reduced to DIV 15 to 21. Recordings were performed at
DIV 20-21. We found that DU-14 significantly increased the baseline frequency of both
activity-dependent sEPSCs and mEPSCs. DU-14 significantly increased sEPSC
frequency when compared to untreated controls and vehicle controls, (19.98 ± 6.8 Hz in
DU-14 treated explants, n=5, compared to 2.14 ± 0.39 Hz in untreated controls, n=4, and
2.71 ± 0.27 Hz in vehicle controls, n=4) (Fig. 5.3A and B). sEPSC amplitude was not
significantly affected by DU-14 treatment (Fig.5.3C). Similarly, baseline mEPSC
frequency was increased by DU-14. However, this increase was only significant when
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compared to untreated controls (0.39 ± 0.11 Hz in untreated controls, n=6 and 8.68 ± 4.54
Hz in DU-14 treated explants, n=7), but there was no significant difference between
untreated controls and vehicle controls (1.98 ± 1.2 Hz, n=5). Moreover, there were no
significant changes in the frequency of sEPSC in vehicle treated controls when compared
to untreated controls (Fig. 5.4A and B). mEPSC amplitude was not affected by DU-14
treatment (Fig. 5.4C). Time to rise and half-width of sEPSCs and mEPSCs were
unaffected by DU-14 treatment (data not shown).

5.4.3 DU-14 exposure does not affect the size of PCs
In whole-cell patch-clamp experiments, rupture of the cell membrane and
introduction of a voltage step allows for the measurement of membrane capacitance and
resistance. The cell capacitance can be used as an indicator of cell surface area. The
membrane resistance represents the number of resting ion channels in the membrane and
their conductances. We compared the cell capacitance values across the three
experimental groups and found no significant differences between the DU-14 treated PCs
and the control groups (Fig. 5.5A). Similarly, there were no significant differences
between the three groups in the membrane resistances of PCs (Fig. 5.5B). Given the lack
of an effect of DU-14 on cell size, and assuming that the overall shape of the membrane
did not change, we can conclude that the average density of resting ion channels in the
membrane was not affected by DU-14 treatment. However, this is not consistent with the
DU-14 increase in sEPSC and mEPSC frequency, since cells of equal size an increased
amount of open channels should be reflected in a decrease in the membrane resistance.
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5.5 Discussion
We have previously shown that in acute cerebellar slices exogenous application of
PregS potently enhanced the frequency of mEPSCs at developing PCs (Zamudio-Bulcock
and Valenzuela, 2011). In humans, PregS has been shown to be present in the cerebellum
(reviewed in (Schumacher et al., 2008)). In the rodent, however, although pregnenolone
has been shown to be synthesized in PCs, the synthesis of its sulfate ester has not been
confirmed (Tsutsui et al., 2003). This study provides evidence suggesting that sulfated
neurosteroids could be synthesized in the cerebellar cortex and that, pharmacologicallyinduced increases of the endogenous levels of this neurosteroid leads to the strengthening
of glutamatergic transmission in PCs in-vitro. In neonatal brain slices, radioimmunoassay
studies have been shown that DU-14 (5 µM) significantly increases the levels of PregSlike neurosteroids (Caldeira et al., 2004). DU-14 inhibits the enzymatic activity of 3-β
hydroxysteroid sulfatases; therefore, in addition to PregS, DU-14 could also increase the
production of other sulfated 3-β hydroxysteroids, which could contribute to the increase
in glutamatergic transmission. For instance, dehydroepiandrosterone sulfate has also been
shown to activate TRPM3 channels, although with lower efficacy than PregS (Wagner et
al., 2008, Majeed et al., 2010). Therefore, the findings reported here could be, in part,
mediated by an increase in endogenous dehydroepiandrosterone sulfate levels.
In the neonatal hippocampus it was shown that postsynaptic depolarization
induced the release of a PregS-like neurosteroid which, acting as a retrograde messenger,
potentiated glutamatergic transmission. It is possible that a similar mechanism takes place
in the developing PC. Thus, DU-14 treatment may set the PC glutamatergic circuit into
an ongoing excitatory loop in which increased levels of endogenous PregS-like
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neurosteroids are retrogradely released upon PC excitation by CF and /or PF activity
stimulating a further enhancement of glutamate release onto PC, resulting in increased
PC excitability thus leading to an ongoing increase in the retrograde release of PregS.
The decrease in PC viability caused by prolonged exposure to DU-14 could be a
consequence of excitotoxicity via the PregS-induced increase in glutamatergic
transmission. Developing, but not mature, PCs dendrites express Ca2+-permeable GluR2lacking AMPA receptors (Douyard et al., 2007). NMDA receptors are expressed in both,
developing and mature PCs, with a transient absence during the third postnatal week
(reviewed in (van Welie et al., 2011)). Therefore, in developing PCs, excessive Ca2+
entrance through AMPA and NMDA receptors, could lead to excitotoxicity and eventual
cell death.
Our findings that chronic exposure to DU-14 significantly increases the average
baseline frequency of mEPSCs and sEPSCs can be interpreted in two ways. In control
PCs, at DIV15 (chronologically equivalent to P10) PregS increases the frequency of
mEPSCs in PCs (526.5 ± 171.7 % of baseline, n=2, data not shown). The K-S test
showed a significant decrease in the inter-event interval. Additionally, in acute slices the
effect of PregS was specific to CF-to-PC synapses and disappeared after P15 (ZamudioBulcock and Valenzuela, 2011). Therefore, although it is uncertain if, after DU-14
washout, the steroid sulfatase enzymatic activity is recovered and PregS levels are
decreased, we expect that at DIV20-21 glutamatergic synapses at PCs are no longer
sensitive to PregS. Making this assumption, we can state that treatment with DU-14
induces a persistent enhancement of glutamatergic transmission. Such persistent
enhancement of glutamatergic transmission could be explained by unsilencing of
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synapses or stabilization of multinumerary CF inputs. The lack of an effect in the
amplitude of both sEPSCs and mEPSCs argues that long term exposure to elevated PregS
levels does not change the density or the conductance of postsynaptic AMPA receptors.
Alternatively, it is possible that chronic exposure to elevated levels of PregS sensitizes
these synapses and if PregS levels are still high in the explant at the time of the
recordings, our results could reflect an ongoing effect of elevated levels of PregS. This
would imply that these synapses do not develop tolerance to PregS.
The ultimate physiological outcome of this pharmacologically-induced increase in
sulfated neurosteroid levels on the development of glutamatergic synapses is yet to be
tested. Preliminary experiments showed that while in control explants, PF and CF-like
currents could be evoked, in DU-14 treated PCs, only PF-like responses could be elicited
(see Appendix 15). These results could indicate that chronic exposure to elevated levels
of sulfated neurosteroids results in the total elimination of CF-to-PC synapses or in a
change in the properties of these synapses. These findings could be relevant in cases of
abnormal elevations of sulfated neurosteroids. In a model of fetal alcohol spectrum
disorders, studies from our laboratory, suggest that prenatal alcohol exposure increases
the levels of PregS, but not of dehydroepiandosterone sulfate, in the fetal brain ((Caldeira
et al., 2004) reviewed in (Valenzuela et al., 2008)). The results presented here suggest
that the level of endogenous PregS-like neurosteroids can be manipulated in culture and
suggest a potential physiological role for these neurosteroids in the development of
glutamatergic synapses onto PCs. Future experiments will make use of the hindbrain
culture system and will aim to decrease endogenous levels of PregS using short hairpin
RNA dependend downregulation of the specific PregS sulfotransferase Sult2b1a and will
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study the development of CF and PF-to-PC synapses (for details see future directions
section).
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5.6 Figure legends
Figure 5.1. Schematic representation of dissection and plating of hindbrain cultures
from rat embryos at E15-16. The location of the cerebellar plates (Cb) and the inferior
olive (IO) are indicated in the lateral and the frontal views. Dash lines indicate cuts.
Adapted from Chedotal et al (1997) and Letellier et al (2009).

Figure 5.2. Prolonged inhibition (DIV12-28) of steroid sulfatases decreases PC
viability. (A) Confocal images of DIV24 hindbrain explants at a magnification of 63X,
the vehicle control is shown on the left and the DU-14 treated is on the right. Scale bars
20 µm. (B) Calbindin fluorescence intensity is significantly lower in DU-14 treated
explants (* p<0.05 by Mann-Whitney test n=3).

Figure 5.3. Shorter inhibition of steroid sulfatases increases the frequency but not
the amplitude of sEPSCs in PCs. (A) Sample traces of sEPSCs recordings at DIV20-21
PCs. Scale bar: 50 pA, 0.5 s. (B) DU-14 significantly increases sEPSC frequency when
compared to both, untreated controls and vehicle controls (*p<0.05 by one-way ANOVA
followed by Dunn's multiple comparison test n=4-5). (C) DU-14 treatment does not
significantly affect the amplitude of sEPSC.

Figure 5.4. DU-14 treatment increases mEPSC frequency. (A) Sample traces of
mEPCs recordings at DIV20-21 PCs. Scale bar: 20 pA, 0.2 s. (B) DU-14 significantly
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increases mEPSC frequency when compared to untreated controls (*p<0.05 by one-way
ANOVA followed by Dunn's Multiple Comparison Test, n=5-7). There was no
significant difference between untreated controls and vehicle controls. (C) DU-14
treatment does not significantly affect the amplitude of mEPSC.
Figure 5.5. DU-14 treatment does not affect PC membrane capacitance or
resistance.

102

Figure 5.1. Schematic representation of dissection and plating of hindbrain cultures
from rat embryos at E15-16.
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Figure 5.2. Prolonged inhibition (DIV12-28) of steroid sulfatases decreases PC
viability.
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Figure 5.3. Shorter inhibition of steroid sulfatases increases the frequency but not
the amplitude of sEPSCs in PCs.
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Figure 5.4. DU-14 treatment increases mEPSC frequency.
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Figure 5.5. DU-14 treatment does not affect PC membrane capacitance or
resistance.
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6. Conclusions
6.1 Summary of main findings
The main findings of the studies presented in this dissertation can be summarized as
follows. First, it was demonstrated that the neuroactive steroid pregnenolone sulfate
(PregS) reversibly modulates GABA and glutamate release at the developing cerebellar
Purkinje cells (PCs). The effect on glutamate release, however, was significantly greater
than that on GABA release. Therefore, the studies were focused on further characterizing
the effect of PregS on glutamate release. This effect was found at climbing fiber (CF)-toPC synapses from neonatal, but not juvenile rats. On the other hand, developing parallel
fiber (PF)-to-PC synapses were not affected in juvenile PCs. Second, the effect of PregS
on glutamate release at immature PCs was Ca2+-dependent and was mediated by
activation of steroid-sensitive transient receptor potential melastatin 3 (TRPM3)
channels. Importantly, this finding identified TRPM3 channels as novel modulators of
glutamatergic transmission in the developing brain. Third, pharmacologically-induced
increases in endogenous PregS-like neurosteroids induce a long-lasting increase in
glutamatergic transmission at PCs in organotypic hindbrain cultures. This effect may
damage PCs via an excitotoxic mechanism and also trigger elimination of CF-PC
synapses.

6.2 Overall conclusions and functional implications
The development of PCs and the formation of GABAergic and glutamatergic
synapses onto these cells are known to be influenced by several factors including
neurotrophins, neurosteroids, and activation of neurotransmitter receptors and calcium
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channels. Nevertheless, the role of the pregnenolone sulfate (PregS)- induced potentiation
of glutamatergic transmission via modulation of the transient receptor potential M3
channel proposed in this dissertation is unprecedented.
During early postmitotic development, remodeling of PC dendrites is controled by
multiple intrinsic factors, including retinoid-related orphan receptor α, a transcription
factor whose expression in PCs modulates early stages of dendritic tree outgrowth and
remodeling (reviewed in (Sotelo and Dusart, 2009)). However, the majority of PC
development events, including migration, survival, dendritic development, and synapse
formation and stabilization depend on interactions with other neuronal and glial cell
types. The migration of PCs, via interactions with radial glia, is modulated by the
extracellular matrix glycoprotein, reelin, released by cells within the external granule cell
layer (reviewed in (Sotelo and Dusart, 2009)). We found that TRPM3 channels are highly
expressed in the external granule cell layer (EGL), where immature granule cells and
radial glia fibers are located. Therefore, it would be interesting to investigate whether
these channels also play a role in the migration of PCs.
Dendritic development and synaptogenesis in PCs are the result of a spatially and
temporally coordinated concert of cell-to-cell interactions in which neurotrophins,
neurosteroids, and activity-dependent mechanisms have been shown to play a role. PCs
receive excitatory inputs from axonal projections of the inferior olive, the CFs, and from
the granule cell projections, the PFs. The first ones to develop are the CF-to-PC synapses,
which contact PCs by E17 (reviewed in (Liu et al., 2008b)). During early development,
the survival of PCs has been suggested to depend on CF synaptic input. In organotypic
slice cerebellar cultures lacking the inferior olive, which give rise to the axonal CF
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projections, the number of PCs is dramatically reduced, an effect that can be rescued by
co-culturing these slices with inferior olive-containing slices. The trophic effect of the CF
input can be mimicked by pharmacologically-induced depolarization of cultured PCs
(Ghoumari et al., 2006). Interestingly, the PregS-induced increase in glutamate release at
CF-to-PC synapses could contribute to the role of CF in PC survival.
Elongation and migration of CF projections from the inferior olive starts at around
embryonic day E13 and has been proposed to be mediated by brain-derived neurotrophic
factor (BDNF) and neurotrophins 3/4 (NT3/4), and their receptors (tropomyosin-related
receptor kinases B and C; TrkB and TrkC, respectively). The levels of these
neurotrophins and their receptors are developmentally regulated, being highest during
embryonic and early postnatal development. NT3 and NT4 are synthesized in the
developing cerebellum, but not in the inferior olive. However, NT3 and NT4 peptides
have been shown to be accumulated in this brain region, suggesting retrograde transport
from the cerebellum. On the other hand, BDNF is synthesized within both the cerebellum
and the inferior olive, and has been proposed to stimulate axonal elongation by
anterograde transport. In BDNF- or NT3- deficient mice, ataxia and behavioral deficits,
consistent with CF-to-PC synapse dysfunction, have been reported (reviewed in (Sherrard
and Bower, 2002)). Interestingly, the expression of neurotrophins is reduced before the
onset of CF synapse elimination and the activation of TrkB decreases in the inferior olive
at the onset of CF regression (Sherrard et al., 2009).
During early CF-to-PC development (first postnatal week), multiple CF inputs are
functionally differentiated via synaptic competition among themselves, resulting in
simultaneous strengthening of one CF input and weakening of the rest. Subsequently, the
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strongest CF translocates from the soma to the proximal dendrites of the emerging
dendritic tree, and the weak CF inputs are eliminated. The mechanism responsible for
such functional differentiation and subsequent elimination is not well understood. It has
been proposed that Ca2+ entrance through α1 -containing P/Q type Ca2+ channels
(Cav2.1), facilitates the strengthening of the winning CF. In mice lacking α1 -containing
P/Q type Ca2+ channels (Cav2.1), multi-innervation by CF persists.

Moreover, PFs

normally synapse onto distal regions of the dendritic tree and also innervate the proximal
dendrites, suggesting that CF functional differentiation and translocation to proximal
dendrites failed to occur (Miyazaki et al., 2004). Additionally, while strong CFs undergo
long-term potentiation, weak CFs display long-term depression in response to the same
stimulation paradigm (Bosman et al., 2008, Ohtsuki and Hirano, 2008). It has been
proposed that the spatial arrangement of the CFs relative to the sites of Ca2+ entry
determines whether they are strengthen or weakened. During the period of functional
differentiation and CF translocation to the dendrites, L-type Ca2+ channels disappear from
the soma and P-type Ca2+ channels start to appear in the emerging dendritic tree
(reviewed in (Bosman and Konnerth, 2009)). PregS has been proposed to be retrogradely
released at CA1 hippocampal pyramidal cells upon application of a depolarization
protocol that mimicked early network-driven oscillatory bursts known to increase
intracellular Ca2+ (Garaschuk et al., 1997, Mameli et al., 2005). In the hippocampus,
increases in intracellular Ca2+ were shown to increase PregS levels (Kimoto et al., 2001).
Additionally, although it is unknown whether the release of PregS from these cells
involves vesicular release or transporter-mediated extrusion, it is known that dendritic
release of retrograde messengers is generally Ca2+-dependent and can be spatially
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restricted (reviewed in (Regehr et al., 2009)). Therefore, it is possible that in PCs the
compartmentalized Ca2+ levels could favor the production and retrograde release of
PregS at the sites with highest intracellular Ca2+. Thus, PregS could contribute to the
strengthening of those CF inputs located at such privileged sites. Our studies on the
PregS-induced increase of glutamate release at these synapses focused on the largest
evoked CF-induced current, which includes the responses of both strong and weak CF
inputs. Therefore, studies evaluating the effect of PregS in strong and weak CFs
separately would be needed to test this hypothesis.
Activation of TrkB receptors was also shown to be required for CF synapse
elimination, as mice lacking this BDNF receptor display persistent CF multi-innervation.
Additionally, in these mice the number of GABAergic synapses is reduced and the
postsynaptic currents are prolonged, suggesting that the GABAA receptors do not
undergo the developmental switch from α3 to α1 subunits (Takayama and Inoue, 2004b,
Bosman et al., 2006). Given that both CFs and a subset of molecular layer interneurons
synapse onto the proximal part of the PC dendritic tree, it has been proposed that
GABAergic interneurons could modulate CF-to-PC synapse formation via synaptic
competition for postsynaptic sites (Bosman and Konnerth, 2009). Thus, in TrkB mutants,
the empty postsynaptic sites could be occupied by CFs. Therefore, it is uncertain whether
TrkB modulates CF-to-PC synapse development directly or indirectly by modulating the
formation of GABAergic inputs onto the PC.
If, endogenous PregS release is favored at sites with high intracellular Ca2+
GABAergic interneuron-to-PC synapses would also be potentiated by PregS. Consistent
with this, we found that GABAergic transmission at neonatal PCs was potentiated by
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PregS, but to a lesser extent than glutamatergic transmission (Zamudio-Bulcock and
Valenzuela, 2011). Although, the mechanism mediating the effect of PregS at
GABAergic synapses remains unknown, given the high expression of TRPM3 in the
EGL, it is possible that this effect of PregS is also mediated by TRPM3. Thus, the
difference in the potency of the effect of PregS at glutamatergic versus GABAergic
synapses could be explained by a different level of expression of TRPM3 channels at
these synapses.
The development of PF-to-PC synapses starts at the end of the first postnatal
week when NT3, BDNF, TRKB, and TRKC, are expressed in both developing PC and
granule cells. Therefore, these neurotrophic factors are thought to be involved in granule
cell development and PF-to-PC maturation (reviewed in (Sherrard and Bower, 2002)). In
developing PCs, the production of BDNF is modulated, at least in part, by the steroid,
estrogen, which is also produced in the PC, and has been linked to PC dendritic growth,
spinogenesis and synaptogenesis. Estrogen deficient mice display altered dendritic
morphology and synaptogenesis and these effects are correlated with decreased BDNF
production. Conversely, estrogen administration to these mice increased BDNF levels in
the cerebellum and improved dendritic growth, spinogenesis, and synaptogenesis
(reviewed in (Tsutsui, 2008)). A proposed mechanism for BDNF- and estrogen- mediated
synaptogenesis is the production of synaptic vesicle proteins, whose expression is
regulated by both estrogen and BDNF (reviewed in (Tsutsui, 2008)). Activation of
glutamate receptors has been shown to upregulate BDNF expression in granule cells
(Lindholm et al., 1993). Therefore, it is also possible that, if PregS increases glutamate
release at neonatal PF-to-PC synapses, the resulting enhancement of postsynaptic AMPA
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receptor activation in PCs could in turn modulate BDNF expression, contributing to the
formation of these synapses.
Synaptic competition between PF and CF inputs has been suggested by a number
of studies where granule cell survival is compromised or functional PFs are absent. These
include studies where mitotic granule cells are ablated by X-irradiation and natural
occurring mutants, the Weaver, Reeler, and the Staggerer mice (reviewed in (Bosman and
Konnerth, 2009)). The glutamate receptor type δ2 (GluR δ2) plays a key role in PF to PC
competition. In the absence of this receptor, which is exclusively expressed in PCs, the
number of spines contacted by PFs is reduced by 50% and the vacant sites are occupied
by CFs, resulting in persistent multiple CF innervation (reviewed in (Bosman and
Konnerth, 2009)). PF-CF synaptic competition could be used to elucidate whether PregS
primarily modulates the development of CFs. If this is the case, decreases of endogenous
PregS levels, as proposed in the future directions section, could result in persistent multiinnervation of weak CFs and failure of CF-PC synapses to translocate to the dendrites;
PFs would occupy the empty sites, producing stronger postsynaptic currents. On the other
hand, if PregS affects PF synapse formation as well, decreased PregS levels would result
in the weakening of both PF and CF inputs.
In summary, the development of synapses onto PCs has been shown to be
modulated by a plethora of factors. However, the precise mechanisms leading to the
appropriate development of glutamatergic and GABAergic transmission are not
understood. The demonstration that PregS and TRPM3 are potent modulators of
glutamatergic transmission contributes another piece to the puzzle of PC synapse
development (Zamudio-Bulcock and Valenzuela 2011, chapter 4). Moreover, the
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widespread expression profile of steroid-sensitive TRPM3 channels in the cerebellar
cortex (Chapter 4 Fig 1) suggests that both PregS and TRPM3 channels could also be key
modulators of granule and PC cell migration, Bergmann glia maturation and PF
elongation.

6.3 Critique and Future Directions.
The effect of PregS on glutamate release at CF-to-PC synapses was found to be
age-dependent, being present in PCs from neonatal (P4-10), but not in juvenile (P15-21)
rats. Moreover, it was not present at PF-to-PC synapses from juvenile rats. However,
additional recordings showed that in juvenile rats (P18-P27) PregS significantly increases
the frequency of mEPSCs (see Appendix 7.8). This increase was considerably smaller
than that observed in neonatal PCs. Maturation of both CF- and PF-to-PC synapses is
completed at the end of the third postnatal week (reviewed in (Valenzuela et al., 2010)).
Therefore, it is possible that after P15, the effect of PregS decreases to levels
undetectable in evoked CF currents, given that the massive release of glutamate nearly
saturates the postsynaptic AMPA receptors (Konnerth et al., 1990). Future experiments
under conditions of low glutamate release probability (induced by low extracellular Ca2+
levels) may unmask an effect of PregS on CF responses in older animals.
It remains uncertain whether before P15 PregS modulates glutamate release at PFto-PC synapses. Although, in agreement with the literature (Scelfo and Strata, 2005), PF
responses were not found in P6-8 PCs, after P8 small PF responses could be detected.
Therefore, it should be revisited whether PregS modulates glutamatergic transmission at
these synapses from P8 to P15.
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Since there are no available specific TRPM3 channel antagonists, the
identification of TRPM3 channels as modulators of glutamatergic transmission required
the use of a number of non-specific pharmacological agents that might affect
glutamatergic transmission by blocking various targets. Mefenamic acid blocks
cyclooxygenases in addition to blocking TRP channels, hence its clinical use as a nonsteroidal inflammatory drug. Interestingly, cyclooxygenase 2 has been shown to regulate
depolarization-induced suppression of inhibition and excitation in hippocampal cells via
modulation of endocannabinoid signalling (Straiker et al., 2011). La3+ is a known nonspecific cation channel blocker. In the hippocampus, however, it has been shown to
potentiate GABAA receptor-mediated currents and to increase the affinity of this receptor
for GABA (Boldyreva, 2005). This finding makes the use of La3+ unsuitable to test the
involvement of TRP channels in the PregS-induce increase of GABA release at
developing PC. Nifedine is a Ca2+ channel blocker that acts predominantly on L-type
Ca2+ channels. These channels are abundantly expressed in the soma of developing PCs
(reviewed in (Bosman and Konnerth, 2009)) and mediate Ca2+ oscillations. Thus,
nifedipine could dramatically affect postsynaptic responses.
The potential implication of PregS and TRPM3 channels in developmental events
such as granule cell and PC migration, Bergmann glia maturation and PF elongation
needs to be experimentally tested. The presence of many other PregS targets within the
developing cerebellar cortex such as, NMDA, σ1, glycine, AMPA, and GABAA
receptors, and voltage-gated Ca2+ channels, indicate that PregS is an important modulator
of its development. For instance, activation of NMDA receptors has been shown to be
essential for the migration of granule cells (Mancini and Atchison, 2007). Also, electron
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microscopy studies have shown that migrating granule cells are in close association with
PC dendrites and Bergmann glia (Yamada et al., 2000); thus, PregS released from PC
dendrites could regulate the migration of granule cells. Alternatively, PregS-mediated
activation of TRPM3 channels on the Bergmann glia could modulate granule cell
migration.
Although numerous studies have provided evidence for the biological relevance
of PregS, the endogenous synthesis of this neurosteroid is controversial. The reason for
this controversy is that direct analytical methods have failed to detect PregS in rat and
mouse brain. Nonetheless, the presence of 3β-hydroxysteroid sulfates in human plasma
and brain, including the cerebellum, has been confirmed. It is noteworthy, however, that
hydroxysteroid sulfotransferases have not been detected in human (reviewed in
(Schumacher et al., 2008)). A number of studies have reported elevated levels of this
steroid in rat and mouse brain and plasma based on indirect methods of analysis, such as
radioimmunoassays and tandem gas chromatography and mass spectrometry. These
methods require prior solvolyzis/hydrolyzis of PregS, and subsequently, the released free
pregnenolone is measured (reviewed in (Schumacher et al., 2008)). A recent study
showed that cholesterol appears to be the main precursor of pregnenolone detected by
tandem gas chromatography and mass spectrometry analysis of the rat brain. This study
suggested that during sample treatment, pregnenolone forms from cholesterol
autoxidation (Liere et al., 2009).
It has been suggested that PregS has not been detected with direct analysis
methods, despite the efforts for improving sample purification and fractionation, because
elevated levels of PregS may only be present within limited regions or compartments
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such as the synaptic cleft. Thus, high local levels of PregS could be diluted in large tissue
samples (Schumacher et al., 2008).
Although PregS per se has not been detected in the rodent brain, there is
compelling evidence of its existence. First, the enzymes involved in its synthesis are
present in the brain. Pregnenolone is sulfonated by cytosolic sulfotransferases (Sult) that
catalyze the transfer of a sulfonate group from the universal sulfonate donor, 3'phosphoadenosine-5'-phosphosulfate, to the hydroxyl group on ring A. Sult2b1
efficiently sulfonates pregnenenolone and, of their two isoforms, Sult2b1a seems to be
specific to pregnenolone, whereas Sult2b1b sulfonates dehydroepiandrosterone,
cholesterol and a number of oxysterols (reviewed in (Schumacher et al., 2008)). The
mRNA for both Sult2b1 isoforms has been detected in whole mouse embryos as early as
E8.5 (Shimizu et al., 2003). The sulfatase that catalyzes the hydrolysis of steroid sulfates
has been shown to be present in mouse brain throughout postnatal development. In the
cerebellum, this sulfatase was present from E18.5 to P9 (Compagnone et al., 1997).
Second, the production of PregS in the brain has been inferred from a number of studies
using pharmacological approaches to increase the levels of endogenous PregS using
sulfatase inhibitors. For instance, administration of the sulfatase inhibitor, DU-14,
enhanced learning and memory in rats and mimicked the PregS-induced enhancement of
paired-pulse facilitation within the hippocampus (reviewed in (Schumacher et al., 2008)).
In the immature hippocampus, alcohol was shown to increase the efficacy of
glutamatergic synapses. This effect was mimicked by application of DU-14 and
prevented by the antibody scavenger that binds pregnenolone-related steroids, suggesting
that this alcohol effect is mediated by the production of PregS-like neurosteroids (Mameli
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and Valenzuela, 2006). In addition, the enhancement of glutamatergic transmission in the
neonatal hippocampus, induced by exogenous application of PregS, was mimicked by
postsynaptic depolarization and this was blocked in the presence of the antibody that
binds to pregnenolone-related steroids. This finding suggests the retrograde release of a
PregS-like neurosteroid at developing hippocampal synapses (Mameli et al., 2005).
Lastly, the DU-14-mediated enhancement of glutamatergic transmission described in
chapter 5, suggests that the degradation of sulfated steroids can be prevented in PCs in
organotypic cultures and this mimicked the enhancing effect of PregS on glutamatergic
transmission at PCs.
Studies using acute slice preparations provided essential information about the
main characteristics of the effects of PregS in neurotransmission at developing PCs.
However, these preparations only provide information on the effect of PregS in the
partially intact cerebellar cortex circuitry. During the preparation of parasagittal slices the
external inputs to the cerebellar cortex, the deep cerebellar nuclei and inferior olive, are
cut. Thus, it is not possible to evaluate potential effects of PregS on these inputs and how
those get integrated in the context of the whole circuit. Moreover, the short-term viability
of the acute slices does not allow the study of long term effects of PregS on PC
neurotransmission.
The functional consequences of the PregS-induced increase in glutamate release
reported in this dissertation will be tested using the hindbrain organotypic culture system
implemented in Aim 3. In these cultures, the endogenous levels of PregS will be reduced
in PCs by downregulation of the steroid cytosolic sulfotransferase SULT2b1 gene
(reviewed in (Schumacher et al., 2008)). To this end, we will use the RNA interference
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and biolistic transfection methods. Specifically, we will use a short hairpin RNA plasmid
for rat Sult2b1 under the control of the U1 promoter and co-expressing the green
fluorescence protein (GFP) gene, which will allow for the identification of transfected
cells. After amplification in bacteria, the plasmid for Sult2b1, or its negative control, will
be biolistically transfected into the explants. During this procedure, the explants will be
bombarded with high velocity gold particles coated with the plasmid (bullets). Cells
where the bullet comes to rest in the nucleus will be transfected. This method allows for
the transfection of a sparse number of cells (Woods and Zito, 2008), such that we will be
able to examine individual PCs in isolation. Non-transfected PCs and PCs transfected
with the negative control plasmid will be used as controls. The timeline of redundant CF
synapse elimination, the achievement of monoinnervation, the developmental increase in
the amplitude of CF and PF responses and cell size will be compared between controls
and PCs transfected with the short hairpin RNA plasmid for Sult2b1.
The retrograde release of PregS also needs to be assessed. Studies performed in
the hippocampus showed that a rabbit anti-PregS IgG blocks the depolarization-induced
increase of mEPSC frequency. A more specific approach for future studies in the
immature PCs could be used. Once it has been established that postsynaptic
depolarization mimics the effect of PregS on glutamate release, the involvement of PregS
can be tested in the hindbrain culture system. Thus, in PCs, where Sult2b1a expression
has been impaired, depolarization-induced enhancement of glutamate release should also
be impaired.
Although knocking down Sult2b1 in specific PCs are necessary to validate the
synthesis of PregS-like neurosteroids in PCs and can provide important information about
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the role of endogenous PregS on the development of synapses onto PCs; given that
TRPM3 was found to be expressed in all layers of the immature cerebellar cortex, the
results could be difficult to interpret. For instance, if the release of PregS from PCs plays
a role in granule cell migration, this would result in reduced or abnormal PF-to-PC
synapse formation, which is known to result in the persistence of multiple CF inputs
(reviewed in (Bosman and Konnerth, 2009)). Therefore, in order to study the effect of
PregS on CF-to-PC development in isolation, the expression of TRPM3 on inferior
olivary neurons could be manipulated. Knock out of TRPM3 channels in inferior olivary
neurons with a RNA interference plasmid coupled with expression of the light-activated
ion channel rhodopsin gene could be used. This would allow us to selectively stimulate
CFs that lack TRPM3.
Given that the development of the cerebellar cortex in hindbrain cultures
resembles in vivo development (Chedotal et al., 1997, Letellier et al., 2009),
manipulations of PregS and TRPM3 expression in hindbrain explants are suitable for
elucidating the physiological roles of endogenous PregS and TRPM3 channels in the
development of the cerebellar cortex. Nonetheless, in vivo studies would be needed for
their validation and to study the behavioral outputs of these manipulations.
Downregulation of PregS synthesis in developing PCs could be achieved by specifically
downregulating Sult2b1 using a promoter specific to the PC, such as the gene encoding
the Purkinje specific protein Pcp2 (Iscru et al., 2009). Using this approach, functional and
morphological studies can be performed. The behavioral test commonly used to evaluate
cerebellar circuitry network function is the conditioning of the eye blink reflex paradigm,
which consists in the temporal pairing of a conditioned stimulus, a tone, with an
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unconditioned stimulus, an air puff. The integration of conditioned and unconditioned
stimuli has been shown to be dependent on activation of the mossy fiber to granule cell
pathway and the CF-to-PC pathway, respectively (reviewed in (Bracha et al., 2009)).
Therefore, it would be interesting to study if developmental PregS downregulation would
affect the outcome of this behavioral test. It would also be interesting to test whether
PregS downregulation throughout the cerebellum would affect PC development
differently than localized downregulation in PCs.
A recent study postulated TRPM3 channels as heat nociceptors (Vriens et al., 2011).
In this study, TRPM3 knockout mice were used. Surprisingly, it was reported that these
animals displayed no obvious deficits in fertility, gross anatomy, body weight, core body
temperature, locomotion, exploratory behaviors, and general somatosensation, excluding
the nocifensive responses to TRPM3 activation (Vriens et al., 2011). In contrast, mutant
mice where PC and granule cell survival, migration, dendritic development, and synapse
formation is impaired, show obvious deficits in cerebellar-dependent functions (reviwed
in (Sotelo and Dusart, 2009)). Therefore, it would be of interest to investigate the
morphological state of the cerebellar cortex in these animals as well as further analyzing
cerebellar function.
Lastly, the findings presented in this dissertation significantly contribute to our
understanding of cerebellar cortex development. It constitutes the first demonstration of
neurosteroid-mediated modulation of neurotransmission in this brain area. The presence
of the effect of PregS in such an active period of synapse formation, dendritic
remodeling, and cell migration, and the potency of such effect, postulates this
neurosteroid as a key modulator of PC development. The PregS involvement in PC
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synapse development could help elucidate the mechanisms underlying cerebellar
malfunctions leading to ataxia and movement disorders in Niemann-Pick type C disease,
a developmental neurodegenerative disease caused by defective intracellular cholesterol
trafficking, which disrupts neurosteroidogenesis, and that is characterized by PC loss,
among other histopathological lesions (Griffin et al., 2004). Since PCs are highly
sensitive to developmental ethanol exposure (Servais et al., 2007), chronic prenatal
ethanol exposure increases the levels of PregS-like neurosteroids in the developing brain,
and ethanol increases the efficacy of immature hippocampal synapses in a PregS-like
neurosteroid-dependent manner (Caldeira et al., 2004, Mameli et al., 2005, Mameli and
Valenzuela, 2006, Valenzuela et al., 2008), the findings presented here could help
elucidate the pathophysiology of the cerebellar alterations that characterize fetal alcohol
spectrum disorders.
The involvement of TRPM3 in the PregS-induced increase in glutamatergic
transmission is the first indication of the role of TRPM3 channels in brain
neurotransmission. Moreover, the abundant expression of TRPM3 in the developing
cerebellar cortex opens up a new area of research to elucidate the roles of these channels
in cerebellar and brain development, broadening our understanding of the processes
involved in neuronal circuit refinement in the central nervous system.
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7. Appendix
7.1 Activity-independent

NMDA

receptor-mediated

increase

in

[Ca2+]i

in

presynaptic terminals of the neonatal CA1 hippocampal area

Purpose of the study
Studies from our laboratory suggested that PregS increases glutamate release in
the hippocampal CA1 region by increasing presynaptic [Ca2+] via activation of NR2Dcontaining NMDA receptors (Mameli et al., 2005). We performed Ca2+ imaging
measurements in presynaptic Schaffer collateral terminals to study the NMDA receptor
activation-mediated increases in presynaptic [Ca2+] in the absence of activity.
Method
In hippocampal slices from P4-5 Sprague-Dawley rats, the Ca2+ indicator
FURA2-AM (10 μM) was injected into Schaffer collaterals with a tip-broken glass
pipette. Then, the indicator was allowed to reach the presynaptic terminals for 1 hour and
fluorometric measurements were performed in a distal region from were the dye had been
injected (Figure 7.1A). NMDA was used to activate the receptors. All experiments were
performed in the presence of TTX (0.5 μM)
Results
We found that bath application of NMDA increased the presynaptic intracellular
Ca2+, as expected. Application of the NMDA receptor blocker DL-APV in the presence
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of NMDA antagonized this increase. Interestingly, ifenprodil, a blocker for NR2Bcontaining NMDA receptors significantly decreased the effect of NMDA (p< 0.0001). As
a control for the terminals’ viability, KCl was applied at the end of every experiment.
However, in 9 out of 10 experiments, NMDA elicited a significant increase in
intracellular Ca (p<0.05 by Wilcoxon Signed Rank Test vs 100).
Conclusion
These results indicate that activation of NMDA receptors in neonatal Schaffer
collateral terminals indeed increases presynaptic [Ca2+]i . However, NR2B-containing
receptors play an important role in this increase. Nonetheless, the significant increase
seen in the presence of ifenprodil could account for activation of PregS-sensitive NR2Dcontaining NMDA receptors. Future experiments would also need to evaluate the
involvement of voltage-gated Ca2+ that could activate downstream of NMDA receptors.
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Figure 7.1. (A) Schematic representation of experimental paradigm. (B) NMDA-induced
increase in [Ca2+]i in the presence (n=10) and the absence (n=7) of ifenprodil. Time is
given in minutes.
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7.2 G-1-mediated activation of the estrogen-sensitive GPR30 receptor does not
modulate

giant

depolarizing

potential

frequency

and

[Ca2+]i

in

hippocampal CA3 pyramidal cells in P7 rats.
Purpose of the study
Activation of the estrogen-sensitive seven transmembrane G protein-coupled
receptor GPR30 increases [Ca2+]i mobilization (Revankar et al., 2005). Neonatal
hippocampal CA3 pyramidal cells display giant depolarizing potentials (GDPs), which
are the result of neuronal network activity and are thought to be involved in the
refinement of developing hippocampal synapses (Ben-Ari, 2001). GDPs trigger transient
increases in [Ca2+]i (reviewed in (Galindo et al., 2005)). GPR30 expression has been
detected in the neonatal hippocampus (Brailoiu et al., 2007). The specific ligand for
GPR30, G-1, has been shown to induce similar increases in [Ca2+]i to those induced by
estrogen. Therefore, we investigated if activation of estrogen-sensitive GPR30 receptors,
can modulate GDPs in neonatal CA3 pyramidal cells and increase [Ca2+]i in the CA3
region.
Methods
GDPs were electrophysiologically recorded as previously described (Galindo et
al., 2005). For calcium imaging experiments, slices were pre-incubated with FURA2-AM
(10 μM) for 10 minutes and subsequently used for fluorometric calcium imaging. The
Ca2+ signal was obtained from IR-DIC-identified CA3 pyramidal and interneuron cell
bodies by first subtracting the background fluorescence from the 350 and 380 nm images,
and subsequently performing a ratiometric analysis of these exposures. G-1 (1 μM) or the
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vehicle DMSO was bath applied and GPDs frequency and Ca2+ signals were compared to
baseline.
Results
G-1 application did not affect the frequency of GDPs. Also, G-1 did not
significantly increase [Ca2+]i in the neonatal hippocampal CA1 region (Fig 8.2).
Conclusion
These results indicate that GPR30 activation does not modulate neonatal neuronal
network activity in the CA3 hippocampal region. Furthermore, these results suggest that
the non-genomic, rapid, estrogen-induced increases in intracellular calcium via GPR30
receptors do not play a role in the modulation of GDPs.
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Figure 7.2. (A) Recordings of GDPs in the presence of DMSO or G-1. Bottom panel
shows time course graph of GDPs normalized frequency (B) Ratiometric calcium
measures in the CA3 region. Unpaired t-test showed no significant difference between
DMSO and G-1 –induced Ca2+ fluorescent changes. Each group represents 1 recording
and each recording includes 5 to 12 cells.
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7.3 PregS reversibly increases the frequency and decreases the amplitude of mPSCs
in PCs in an age dependent manner
Purpose of the experiment
To study the effects of PregS on combined glutamatergic, and GABAergicmPSCs.
Method
Electrophysiological recordings were made in the whole-cell patch-clamp
configuration from cerebellar PCs at P4 to P12. The cells were divided into three groups
according to their developmental stage P4-5, P7-8 and P9-12. mPSCs were recorded at a
holding potential of -70 mV using an internal solution containing a high Clconcentration. Under these conditions, both cationic currents mediated by AMPA
receptors as well as Cl- currents mediated by GABAA receptors were inward.
Results
A five-minute bath application of PregS (25 μM) reversibly increased the
frequency of mPSCs at P4-5 and P7-8 but not at P9-12 (Fig. 7.3). This effect was most
robust at P4-5, declined, but was still significant, at P7-8, and was not statistically
significant at P9-12. PregS started to increase mPSCs frequency within 1.5 minutes after
bath application began. The frequency went back to baseline values after approximately 8
minutes of washout (Fig 7.3). In addition to the increase in frequency, PregS also induced
a decrease in the amplitude and half-width of mPSCs at P4-5 and P7-8 but not at P9-12.
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Conclusions
These experiments reflected the PregS-mediated increases in both glutamate and
GABAergic transmission. The PregS effect on the amplitude of these events reflects the
inhibition of GABAA receptors by PregS, as it was later confirmed that this effect on the
amplitude is exclusive to GABAA-mPSCs (Zamudio-Bulcock and Valenzuela., 2011).
However, the decrease in half-width could not be seen in isolated GABAA currents and
therefore it remains unexplained. The age dependency of the PregS-induced increase in
mPSCs could be due to an age induced reduction in the PregS potency for AMPA-mPSC
modulation. Alternatively, a decrease in the ability to detect AMPA-mPSCs under these
recording conditions might explain such age dependency, as, paradoxically, isolated
AMPA-mPSCs did not show an age-dependent increase in frequency or amplitude
(appendix 6), suggesting that there could be an age-dependent decrease in our ability to
detect these events under these recording conditions. This could be due to increased
complexity of dendritic arborizations with the consequent movement of synapses to more
distal locations, away for the recording electrode.
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Figure 7.3. Pregs reversibly increases the frequency and decreases the amplitude and
half-width of mPSCs in PCs in an age-dependent manner. 25 μM Pregs increases the
frequency (a1) and decreases the amplitude (a2) of mPSCs in PCs at P4 and P8 but not at
P12. Calibration: a1: 20 pA, 1 sec; a2:.10.2 pA, 13msec. b1, Left panel, time course of
the effect of 5-min application of 25 μM Pregs on mPSC frequency in individual PCs at
P4, P8 and P12. Right panel, PregS increases mPSC frequency at P4-5 (n=6) and P7-8
(n=7) but not at P9-12 (n=8). b2, PregS significantly decreases mPSC amplitude and halfwidth of mIPSCs at P4-5 and P7-8 but not at P12. (* p<0.05, **p<0.01).
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7.4 NMDA receptor activation increases mPSC frequency in an age dependent
manner in developing PCs

Purpose of the experiment
Activation of presynaptic NMDARs enhances GABA release onto developing
cerebellar PCs (Glitsch and Marty, 1999, Duguid and Smart, 2004, Glitsch, 2008). In the
immature hippocampus, PregS enhances glutamatergic transmission via modulation of
presynaptic NMDA receptors (Mameli et al., 2005). Therefore, we tested if NMDA bath
application could mimic the age dependency of the effect of PregS on the frequency of
mPSCs in P4-12 PCs.
Method
mPSCs were recorded using a CsCl internal solution in the presence of TTX (0.5
µM) at a holding potential of -70 mV; 100 μM DL-APV was used to block NMDA
receptors. Recordings were grouped according to age in three groups P4-5, P7-8 and P912.
Results
NMDA bath application induced an increase in mPSCs. Similarly to the Pregs
effect this effect was also age-dependent. NMDA did not have an effect on the amplitude
of these events.
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Conclusion
This results are in agreement with reports showing that NMDA (15 μM) bath
application significantly enhances the frequency of mIPSCs by about 140% in rats aged
P11-14 (Glitsch and Marty, 1999). We show that in recordings of combined GABAA- and
AMPA-mediated mPSCs from younger PCs (P4-5), the same concentration of NMDA
can induce increases higher than 1,000 %. This suggests that in neonate PCs, NMDA
receptors act as potent modulators of synaptic neurotransmission, although based on this
result we cannot discern whether glutamatergic and/or GABAergic synapses are affected
by NMDAR activation. It has also been shown that at this age CF stimulation increases
[Ca2+]i, thereby increasing GABA release onto PC via modulation of NMDARs.
Therefore, if a similar glutamate-to-GABA synapse modulation can occur in activityindependent neurotransmission, it is possible that in the absence of glutamate receptor
blockers glutamatergic synapses contribute to the NMDA-induced increase in GABA
release onto PC.
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Figure 7.4. A. Sample traces illustrating the effect NMDA application on mPSCs . B. NMDAinduced increase in mPSCs frequency at P4-5 (1,193 ± 335 % of baseline, n=4), P7-8 (384.7
±112.3 % of baseline, n=4) and P9-12 (187.6 ± 20.08 % of baseline, n=5). Note age dependency
of the increase. C. NMDA did not affect mPSC amplitude or half-width .
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7.5 GABAA receptor- and AMPA receptor-mediated events differentially contribute
to mPSCs in PCs in an age-dependent manner

Purpose of the experiment
Under the recording conditions described in appendix 7.3, a mixture of action
potential-independent GABAA receptor as well as AMPA receptor-mediated events were
studied. In order to determine whether the effect of PregS was specific to GABAergic or
to glutamatergic synapses, we first determined the percent contribution of GABAA
receptor- and AMPA receptor-mediated events at the different ages studied.

Method
We recorded a 5 minute mPSC baseline (as previously described in appendix 7.3)
followed by a 5 min exposure to 10 µM gabazine to block GABAA receptor-mediated
events (GABAA-mPSCs) in P4-5, P7-8 and P9-12 PCs. Subsequently, AMPA receptormediated events were blocked by adding 50 µM GYKI-53655 to the solution. At all ages,
when GYKI-53655 was added to the solution in presence of gabazine all events
disappeared, suggesting that at these ages all miniature events recorded resulted
exclusively from activation of GABAA and/or AMPA receptors on PCs. Therefore,
application of gabazine resulted in isolation of AMPA receptor-mediated events (AMPAmEPSCs).
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Results
At P4-5, GABAA-mPSCs and AMPA-mEPSCs contribute equally to the
frequency of mPSCs. However, as the cells grow, AMPA-mEPSC contribution decreases.
Also, the percent amplitude of AMPA-mEPSCs with respect to the total amplitude of
mPSCs decreases with age. This result could be explained by the developmental increase
in GABAA-mPSC amplitude. In our recording conditions, the detection of Cl- ions
currents through GABAA receptors is favored. Additionally, it is possible that the
developmental increase in the amplitude of AMPA-mEPSC is not well detected under our
experimental conditions (see appendix 6).
Conclusion
When simultaneously recording GABAA- and AMPA- mediated mPSCs in
developing PCs using a high Cl- internal solution, and holding the membrane potential at
-70 mV, the majority of the events are mediated by GABAA channels at P7-12. However,
at younger ages (P4-5) half of the mPSCs are mediated by AMPA channels. This could
be due to the small size of PCs at this age and to the somatic location of glutamatergic
synapses at this age, but as the cell grows and some synapses are translocated to the
newly formed dendritic tree, filtering of AMPA mediated events might occur.
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Figure 7.5. GABAA-mPSCs and AMPA-mEPSCs differentially contribute to mPSCs in an agedependent manner. A. sample traces of recordings from PCs at P4, 8 and 11 upon consecutive 5
min application of gabazine and GYKI-53655 (gyki), calibration: 20 pA, 500 ms. B. The percent
contribution of AMPA-mEPSCs to mPSC frequency varies with age at P4-5 it is 51.73 ±14.91%
of mPSC baseline (n=6), at P7-8 decreases to 11.52 ± 3.87% (n=4), and P9-12 it decreases even
further to 2.28 ±0.75% (n=7). C. The percent contribution of AMPA-mEPSCs to mPSC average
amplitude also decreases with age. At P4-5 56.11 ± 13.02 %, at P7-8 32.26 ± 7.27 % and at P9-12
24.94 ± 3.25 %.
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7.6 The action potential-independent glutamatergic and GABAergic synaptic
activity recorded in developing PCs gradually increases with respect to
age.

Purpose of the experiment
We noticed that the amplitude, the frequency and the half-width of mPSCs
increased with age, reflecting the synapse formation and stabilization that occurs during
development. Therefore we generated a table of the average frequency and amplitude of
mPSCs and isolated GABAA- and AMPA- mediated mPSCs between P4 and 12.
Method
mPSCs recordings from PCs were divided into three age groups; namely, P4-5,
P7-8 and P9-12. The average frequency, amplitude and half-width were calculated for
each group and the table was generated. Isolated GABAA-mPSCs and AMPA-mPSCs
were recorded at P4-5 and P7-8.
Results
The amplitude and frequency of mPSCs increased with age. Additionally,
recording of isolated AMPA-mPSCs or GABAA-mPSCs revealed that while the
frequency and the amplitude of GABAA-mPSCs significantly increased from P4-5 to P912 (p <0.05 by unpaired t test); the frequency and the amplitude of AMPA-mPSCs did
not significantly change with age.
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Conclusions
The increases and amplitude and frequency of GABAA-mPSCs reflect the
synaptic development of MLI-to-PC synapses during the neonatal period. The increase in
the frequency of these events is in agreement with the previously reported increase in the
frequency of GABAA-mPSCs at PCs at P2-12 (Kawa, 2003). However, this author found
that the amplitude of these events increased up until P10, but decreased by P12 (Kawa,
2003). The lack of a developmental increase in both the frequency and the amplitude of
AMPA-mPSCs is, however, unexpected. Kawa (2003), also found a developmental
increase in the frequency of AMPA-mPSCs in P2 to 12 PCs. On the other hand, he found
that the amplitude of these events increased from P4 to P10, but decreased back to P4
levels by P12 (Kawa, 2003). We also found a trend toward a decrease in the amplitude of
these events at P9-12. The decrease in the amplitude of both GABAA-mPSCs and
AMPA-mPSCs could be explained by enhanced filtering in the growing dendrites of PCs.
Nonetheless, we did not see such developmental decrease in the amplitude of GABAAmPSCs, and this could be explained by the increase in the driving force of Cl- ions caused
by our CsCl based internal solution. The recording conditions between our experiments
and those of Kawa (2003) were different and could explain the discrepancies in the
developmental changes in AMPA-mPSCs amplitude and frequency. This author used a
Cs-methenasulfonate based internal solution and simultaneously recorded GABAAmPSCs and GABA-mPSCs at a holding potential of -40 mV, at which GABAA-mPSCs
and AMPA-mPSCs appear as outward and inward currents, respectively. At -40 mV the
driving force for cations currents mediating mEPSCs is lower than under the holding
potential we used, -70 mV. Consistent with this, while Kawa (2003) detected amplitudes
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of AMPA-mPSCs to be around 9 pA at P4, we detected these currents to be around 25 pA
at the same age. Also, under our recording conditions we found slightly higher
frequencies of these events at P4-5 than those reported in this study. This would be
consisted with the increased capability to detect AMPA-mPSCs at this age. Nevertheless
at P7-8 and P9-12, this apparent advantage to detect AMPA-mPSC is not consistent with
our inability to detect the developmental increases in the frequency and the amplitude of
AMPA-mPSC. Nonetheless, the developmental decrease in the amplitude of these events,
could at least in part, explain the lack of an increase in their frequency. That is, as the
events became smaller, we were unable to detect them.
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Fig 7.6. Postnatal development of miniature synaptic currents frequency and amplitude in PCs.
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7.7 The magnitude of the PregS-induced increase in mEPSC frequency in P9-12 PCs
is not different at 10, 20 and 50 μM.

Purpose of the experiment
To test the concentration dependency of the PregS-induced increase in the
frequency of mEPSCs in immature PCs.
Method
Recordings of mEPSC were performed using a Cs-Gluconate based internal
solution and in the presence of the GABAA receptor blocker, bicuculline (20 μM) and
TTX (0.5 µM) at a holding potential of -65 mV. PregS was bath applied at 3 different
concentrations 10, 20, and 50 μM . Frequency and amplitude changes with respect to
baseline were analyzed.
Results
PregS significantly and reversibly increased the frequency of mEPSCs at
concentrations of 10, 20, and 50 μM. However, this effect was not significantly different
between the concentrations tested (p >0.05 by Dunn’s multiple comparison test). PregS
did not change the amplitude of these events at any of the concentrations tested (Fig 8.7).
Conclusions
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In the hippocampus, 17 µM PREGS is the lowest concentration that induces a
significant increase in glutamate release (Mameli et al., 2005). Here in, we found that 10
µM PREGS induces a significant increase in the frequency of mEPSCs, indicating that
PregS potency is higher in the cerebellum than in the hippocampus. In separate
experiments in P4-10 PCs, we found that an even lower concentration of PregS (5 μM)
significantly enhanced mEPSC frequency (401.1±114.7% of baseline), but this effect was
smaller than the effect of 25 µM PregS (Zamudio-Bulcock and Valenzuela., 2011).
Together these results indicate that at a concentration higher than 5 µM, but lower than
10 µM, the effect of PregS on glutamatergic transmission in the developing cerebellar
cortex reaches a plateau.
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Figure 7.7. A. PregS at concentrations of 10 μM (n=3), 20 μM (n=6) and 50 μM (n=4) increases
mEPSC frequency (***p<0.05 by one sample t-test vs. 100). B. PregS does not significantly
change the amplitude of mEPSCs (p>0.05 by Wilcoxon Signed Rank Test).
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7.8 PregS also increases mEPSC frequency in juvenile P18-27 cerebellar PCs.

Purpose of the experiment
To test whether PregS modulates glutamatergic transmission in juvenile PCs.
Method
Recordings of mEPSC were performed using a Cs-Gluconate based internal
solution and in the presence of the GABAA receptor blocker, bicuculline (20 μM) and
TTX (0.5 µM) at a holding potential of -65 mV. PregS (20 μM) was bath applied for 5
minutes. Frequency changes with respect to baseline were analyzed.
Results
PregS significantly and reversibly increased the frequency of mEPSCs in juvenile
PCs (223.1 ± 24.18% of baseline).
Conclusions
These data suggest that PregS modulates glutamatergic transmission onto PCs
beyond the neonatal period. However, this effect is considerably smaller than the effect
seen in the neonatal period, suggesting that PregS role on glutamate release is strongest
during synapse formation and stabilization. Although this is an important piece of
information and it would be interesting to elucidate the physiological role of PregS in the
juvenile PCs, comparisons between the results obtained in the neonate vs the juvenile
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groups should be made with caution. These data were collected under different
experimental conditions i.e. different internal solution, slightly lower PregS
concentration, and using a different GABAA receptor blocker. Therefore, these results
need to be validated using the same experimental conditions employed in experiments

A

Baseline

B

20 µM PregS
Washout
20 pA
200 ms

Frequency, % of baseline

with neonatal PCs.

250

**

200
150
100
50
0

20 μ M PregS

Figure 7.8. A. Sample traces of mEPSC recordings from a P24 cerebellar Purkinje neuron; 20
μM PregS transiently increased the number of events. B. PregS significantly increases the
frequency of mEPSCs in PCs at P18-27 (**p < 0.05 by t-test vs. baseline, n=4).
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7.9 The Sigma 1 Receptor agonist PRE-084 does affect glutamate release onto
Purkinje cells at P9 to P12.

Purpose of the experiment
In cultured hippocampal neurons, PregS increases glutamate release transiently
via modulation of σ1 receptors (Meyer et al., 2002). Therefore, we investigated if
activation of σ1 receptors could mimic the PregS-induced increase of mEPSC frequency
in P9-12 cerebellar PCs.
Methods
Recordings of mEPSC were performed using a Cs-Gluconate based internal
solution and in the presence of the GABAA receptor blocker, bicuculline (20 μM), and
TTX (0.5 µM) at a holding potential of -65 mV. The σ1 receptor agonist 2-(4Morpholinethyl)

1-phenylcyclohexanecarboxylate

hydrochloride

(PRE-084

hydrochloride), at a concentration of 1 μM, was bath applied. Frequency and amplitude
changes with respect to baseline were analyzed.
Results
PRE-084 significantly changed neither the frequency nor the amplitude of
mEPSCs in P9-12 PCs.
Conclusions

146

These data suggest that σ1 receptors do not play a role in glutamatergic
transmission onto developing PCs and further support the data showing that these
receptors are not involved in the PregS effect on glutamate release onto neonatal PCs
(Figure 2. (Zamudio-Bulcock and Valenzuela, 2011))
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Figure 7.9. σ1 receptor agonism did not mimic the PREGS induced increase in mEPSCs
frequency A. Sample traces of mEPSCs in a P9 PC. B. The amplitude and the frequency of
mEPSCs remained unchanged upon PRE-084 application (p>0.05 by Wilcoxon Signed Rank Test
vs 100).
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7.10 The PregS-induced increase in GABA release onto neonatal PCs could depend
on NMDA and/or glycine receptor activation

Purpose of the experiment
Activation of NMDA receptors has been shown to increase GABA release onto
developing PCs (Glitsch and Marty, 1999, Duguid and Smart, 2004, Glitsch, 2008).
Activation of glycine receptors has also been shown to facilitate both glutamate and
GABAergic transmission onto developing PCs (Kawa, 2003). Therefore, we investigated
the involvement of these receptors in the PregS-induced increase of GABAA-mPSC
frequency in neonatal P4-5 PCs.
Methods
We first investigated the effect of NMDA and glycine receptor blockade on the
effect of PregS on combined AMPA and GABAA –mPSCs (mPSCs) recorded in the
presence of TTX (0.5 μM). Then, isolated GABAA-mPSC were recorded from P4-5 PCs
in the presence of GYKI 53655 (50 μM) and TTX (0.5 μM). NMDA and glycine
receptors were blocked with DL-2-Amino-5-phosphonopentanoic acid (DL-APV) (100
μM) and strychnine (1 μM), respectively. All experiments were performed using the
same CsCl based internal solution as in Zamudio-Bulcock and Valenzuela (2011).
Results
In the presence of DL-APV and strychnine the PregS-induced effects on the
frequency and amplitude of mPSCs, in P7-8 PCs, was significantly reduced (Figure
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8.10A). Additionally, we found that at P4-5, in the presence of the NMDA and glycine
receptor blockers, PregS did not significantly increase the frequency of GABAA-mPSC
(Figure 8.10B). The K-S test showed that in only 1 out of 5 cells PregS induced a
significant decrease in the inter-event interval. Similarly, the average amplitude of these
events was not significantly affected by PregS in the presence of NMDA and glycine
receptor blockers. K-S test showed that in 2 out of 5 cells PregS induced a significant
decrease in the amplitude of GABAA-mPSC.
Conclusions
These results suggest that activation of NMDA and or glycine receptors could be
involved in the effects of PregS on mPSC frequency and amplitude. Experiments on
isolated AMPA-mPSC showed that NMDA and glycine receptors are not involved in the
effect of PregS on glutamatergic transmission at neonatal PCs (Zamudio-Bulcock and
Valenzuela, 2011). Therefore, we can deduce that the role of NMDA and glycine
receptors on the effect of PregS is specific to GABAA-mPSCs. PregS significantly
increases the frequency and decreases the amplitude of GABAA-mPSC at P4 to P8
(Zamudio-Bulcock and Valenzuela, 2011). However, when only P4-5 PCs are
considered, the K-S test shows that PregS induced a significant decrease in the interevent interval in 3 out of 5 cells. Similarly, the K-S test also showed that in only 2 out 5
cells PregS induced a significant decrease in the amplitude of these events. These data
suggest that the effect of PregS on GABA release onto developing PCs is highly variable.
Therefore, from the experiments presented here, it is not clear whether or not NMDA
and/or glycine receptors play a role in this effect. An increase in the number of
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experimental values and the inclusion of recordings at P7-8 would be necessary in order
to reach conclusive results.
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Figure 7.10. A. At P7-8, the presence of both, DL-APV and strychnine significantly reduced the
PregS-induced increase in mPSC frequency (left panel, **p < 0.01 by Dunn's Multiple
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7.11 The P450scc inhibitor, aminogluthetamide aminoglutethimide, significantly
decreases depolarization-induced potentiation of inhibition

Purpose of the experiment
PC depolarization or CF stimulation increase [Ca2+]i in PC dendrites and induces
a short term depression in GABA release followed by a longer and transient enhancement
in GABA release onto PCs. This transient enhancement in GABA release is called
depolarization-induced potentiation of inhibition (DPI) and has been ascribed to
activation of NMDA receptors by retrogradely released glutamate. We tested whether
neurosteroids could play a role in this phenomenon.
Methods
In these experiments, we recorded mIPSCs from P9-12 PCs using a CsCl based
internal solution in the presence of TTX (0.5 μM) and NBQX (10 μM). To reduce
endogenous neurosteroid production, the experimental group was pre-incubated, for 20
minutes at 34o, with aminoglutethimide (AMG), a specific P450scc inhibitor. After a 5
minute baseline recording, the PC was given five depolarizing pulses from -70 mV to 0
mV; pulse duration was 1 s and the inter-event interval was 10 ms.
Results
We found that blockade of neurosteroid synthesis significantly decreases DPI.
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Conclusion
These results suggest that in PCs, which are highly neurosteroidogenic, induction
of DPI may be modulated by neurosteroids.
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Figure 7.11. A. Sample traces of mIPSC recordings obtained before and after PC depolarization

in a control at P9 and an AMG treated PC at P12. B.. mIPSC frequency time course in the
absence and presence of AMG. C. Summary of AMG effects on DPI (*** p< 0.0001; **
p< 0.01, n=4-5).

152

7.12 Brief characterization of organotypic slice cerebellar culture development and
sensitivity to PregS.

Purpose of the experiment
The initial objective of these experiments was to implement a culture system that
would allow us to study the role of PregS on synaptic development onto PCs by
modulating PregS levels in the slices. The set of data shown here corresponds to a brief
characterization of synaptic activity development and PregS sensitivity of PCs in this
culture system.
Methods
Parasagittal cerebellar slices (400 μm thick) from 1 day old rats were plated and
kept at 37oC in 95 % O2 – 5% CO2 for up to three weeks. The culture media contained
50% Eagle’s basal medium, 25% heat inactivated horse serum, 25% Earle’s balanced salt
solution and 1% penicillin/streptomycin. Electrophysiological experiments were
performed at days in vitro (DIV) 8, 10-12 and 19. Spontaneous firing frequency was
recorded in the cell-attached mode. Whole-cell voltage-clamp was used to record
spontaneous GABA and glutamate-mediated currents (sIPSCs and sEPSCs, respectively)
using a CsCl based internal solution in the absence of synaptic blockers. mIPSCs were
recorded in the presence of TTX (0.5 μM) and NBQX (10 μM). Complex-like spike
activity was recorded in the whole-cell current-clamp mode. PregS was used at a
concentration of 25 μM.

153

Results
In agreement with previous reports (Seil et al., 1978, Drake-Baumann and Seil,
1999) our results show that in cerebellar slice cultures PC electrical activity and synapse
formation develop in a way that resembles in vivo development. First, PC spontaneous
firing frequency increases with age (Figure 8.12A). This finding is in agreement with a
previous study demonstrating that, similar to in vivo development, spontaneous action
potential in the cortex of organotypic cerebellar cultures increases with age (Seil et al.,
1978). Second, the frequency of sPSCs (sEPSCs+sIPSCs) increases as the culture
matures (Figure 8.12B). The frequency of spontaneous excitatory postsynaptic currents
(sEPSCs) as well as inhibitory postsynaptic currents (sIPSCs) has been shown to increase
during PC development in acute slice preparations (Kawa, 2002). Additionally, it has
been shown that complex spikes are the predominant spike form in PCs in cerebellar
cultures (Lonchamp et al., 2006). This spontaneous complex spike-like activity was also
seen in cerebellar cultures (Figure 8.12C). Interestingly, this activity does not seem to be
dependent on AMPA receptor activation, as NBQX did not block it (not shown).
Importantly, we found that developing PCs in organotypic cultures are sensitive to PregS
(Figure 8.12D). At DIV 8-9, bath application of 25 μM PregS significantly and reversibly
increases mIPSC frequency.
Conclusions
Our data are in agreement with previous reports characterizing the development
of PC synapses in organotypic slice cultures. In this system, PCs receive GABAergic as
well as glutamatergic synapses. We show that, similar to in acute slice preparations,
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PregS enhances GABAergic transmission in developing PCs. In this system
glutamatergic inputs to PCs arrive from granule cells projections that develop in a PF-like
fashion (Dupont et al., 2006). Granule cell proliferation and migration from the outer
granule cell layer to the inner granule cell layer occurs in cerebellar slice cultures
(Mancini and Atchison, 2007). However, in this system the inferior olivary inputs to the
cerebellar cortex, the CFs, are severed. Therefore, CF-to-PC synapse development cannot
be studied in cerebellar slice cultures.
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Figure 7.12 . A. In cultured cerebellar slices, the frequency of spontaneous firing in PCs
increases with age. Bottom panel shows spontaneous firing frequency values at different ages
(n=1-2). B. The frequency of GABA + glutamate spontaneous events increases with age (n=2-3).
C. Complex spike-like activity recorded form a PC at DIV 12. D. PregS increases the frequency
of mIPSCs in DIV 8 and 10 PCs. The top panel shows mIPSCs recordings in the presence of
PregS from a DIV 8 PC. The bottom panel shows bar graph summary of PregS effect in DIV8-10
PCs. K-S test showed a significant decrease in inter-event interval (n=3).
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7.13 The TRPC channel blocker SKF96365 does not block the PregS-induced
increase in AMPA-mEPSCs
Purpose of the experiment
In acutely isolated dentate gyrus hilar neurons, PregS enhances spontaneous
glutamate release by inducing presynaptic Ca2+-induced Ca2+ release. Activation of
TRPC channels has been proposed to mediate this effect of PregS (Lee et al., 2010).
Additionally, the immature cerebellum expresses TRPC1-7 channel proteins as early as
P1. Interestingly, TRPC3 is predominantly expressed in the PC layer (Huang et al.,
2007a). SKF96365 is an antagonist for TRPC channels as well as store-operated calcium
channels and voltage-gated calcium channels and it was shown to block the effects of
PregS in the dentate gyrus (Lee et al., 2010). Importantly, this agent is inactive at TRPM3
channels (Grimm et al., 2003). Therefore, we investigated if TRPC channels could
mediate the PregS-induced increase of glutamate release onto neonatal PCs.
Method
AMPA-mEPSCs were recorded as previously described (Zamudio-Bulcock and
Valenzuela, 2011). PregS (25 μM) was bath applied in the presence of SKF96365 (100
μM) (Tocris Bioscience, Ellisville, MO).
Result
Blockade of TRPC channels does not prevent the PregS effect on glutamatergic
synaptic transmission at P4-5 PCs.
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Conclusion
This result indicates that TRPC channels do not play a role in the effect of PregS.
Nonetheless, given their abundant expression in the PC layer in the neonate (TRPC3),
their potential role in the modulation of glutamatergic transmission should be further
studied.
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Figure 7.13: A. Sample traces of AMPA-mPSCs in the presence of SKF96365 in a P5 PC. B. In
the presence of SKF96365, PregS increased the frequency of these events (2,691 ± 1,565 % of
baseline; raw change from baseline 14.07 ± 4.12 Hz; n=3). The K-S test showed a significant
decrease in the inter-event interval in 3 recordings.
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7.14 Climbing fiber innervation of Purkinje cells in rat hindbrain cultures

Purpose of the experiment
In mouse hindbrain cultures the development of CF-to-PC synapses has been
shown to resemble the in vivo maturation of these synapses. First, multiple CF synapse
onto PCs and subsequently redundant CF inputs are eliminated (Letellier et al., 2009). In
this set of experiments we assessed CF innervation onto PCs in rat hindbrain cultures.
Methods
We cultured hindbrain explants from rat embryos at DIV 15, as described in
Chapter 6, and evaluated CF innervation at DIV 18-23, chronologically equivalent to
P13-18. In acute slices it has been shown that after P13 the majority of PCs are
monoinnervated (Hashimoto et al., 2009). In mouse hindbrain cultures, plated at
embryonic day 14, the majority of PCs are monoinnervated at DIV 21, chronologically
equivalent to P15. CF-evoked excitatory postsynaptic currents (CF-eEPSCs) were
recorded as previously described in Zamudio-Bulcock and Valenzuela (2011). The
stimulating electrode was placed in the region near the PC, approximately 200 μm apart.
The membrane potential was held at -70mV. Paired-pulses were delivered with an interevent interval of 50ms. The stimulation intensities varied from 10 to 100μA.
Immunohistochemistry experiments were performed as described in Chapter 6;
additionally, guinea pig anti-VGlut2 was used to assess the presence of CF terminals in
the explants.
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Results
We found that in control explants, CF e-EPSCs could elicit paired-pulse
depression, indicating the presence of CF inputs at PCs. This result is expected, given the
age of the explants (DIV 18 -23). In 3 cells, CF-evoked currents showed a single all or
none current step, indicating that these cells were monoinnervated (Fig. 8.14 B, C, D).
Additionally, we found VGlut2 expression surrounding the PCs at DIV20-28 (Fig. 8.14
A).
Conclusion
In agreement with previous reports (Chedotal et al., 1997, Letellier et al., 2009),
we found that CFs contact PCs in hindbrain cultures. Importantly, at mature stages they
show monoinnervation. These results set the groundwork for future studies to investigate
the role of sulfated steroids in the achievement of CF-to-PC monoinnervation.
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Figure 7.14: A. Confocal image showing calbindin positive PC and VGlut2 positive
glutamatergic terminals in a rat hindbrain explant at DIV 28. B. Sample trace of CF-eEPSC
recording, showing paired-pulse depression. Scale bar: 200 pA, 50 ms. C. Corresponding plot,
showing CF characteristic all or non responses. D. Average plot of CF-eEPSC1 amplitudes in 3
PC at DIV18-23.
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7.15 Evoked excitatory postsynaptic currents in Purkinje cells from rat hindbrain
cultures exposed to the sulfatase inhibitor DU-14

Purpose of the study
To assess whether CF innervation onto PCs is affected by increased levels of
endogenous PregS-like neurosteroids via chronic treatment of rat hindbrain cultures with
the sulfatase inhibitor DU-14.
Methods
Hindbrain explants were treated from DIV12-24 with either DU-14 (5 μM) or
with the vehicle, DMSO. At DIV22-23, whole-cell patch-clamp recordings from PCs and
stimulation of eEPSCs were performed as previously described in Zamudio-Bulcock and
Valenzuela (2011) and Appendix 14. The paired-pulse ratio (PPR) was calculated as
eEPSC2/eEPSC1.
Results
We found that while in the DMSO controls both paired-pulse depression and
paired-pulse facilitation could be elicited in two out of 3 cells; the other cell exhibited
paired-pulse facilitation only (Fig. 8.15 A), consistent with the presence of CF and PF
inputs at this developmental stage. In the DU-14 exposed explants, the paired-pulse
depression population was absent in recordings from 3 different cells (Fig. 8.15 B).
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Conclusions
These preliminary data suggests that chronic increases in PregS-like neurosteroid
levels may induce the loss of CF inputs. Chronic activation of TRPM3 channels in CF
terminals and the resulting increases in intracellular Ca2+ could result in Ca2+ overload
and eventual elimination of the terminals. Alternatively, increased PregS levels could
induce a change in the probability of glutamate release at CF synapses. Unfortunately, it
was difficult to assess the presence of all-or-none responses in both experimental groups.
This could be due to contamination of the responses with PF-induced currents, alternating
with CF-induced currents. These confounds need to be addressed in future experiments
prior to examining the role of PregS-like neurosteroids in the development of
glutamatergic synapses at PCs.
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